Amedeo Smart

Free Medical Literature Service

 

Amedeo

Bacterial Infections and Mycoses
  Free Subscription

Articles published in
Clin Infect Dis
    October 2026
  1. SINGH UB, DiBona K, Shaikh S, Mattoo SK, et al
    Not All Extrapulmonary Tuberculosis Is Equal: Site-Specific Mortality in a National Indian Cohort.
    Clin Infect Dis. 2026 Oct 19:ciag677. doi: 10.1093.
    >> Share

  2. KONG EL, Kubiak DW, Shenoy ES, Letourneau AR, et al
    Antibiotic Stewardship, Resistance, and Mortality in Vancomycin-Resistant Enterococcus: A Quasi-Experimental Study of Linezolid Restrictions.
    Clin Infect Dis. 2026 Oct 16:ciag656. doi: 10.1093.
    >> Share

  3. GISPEN F, Mao J, Karan K, Bao Y, et al
    Outpatient Antibiotic Fills and 30-Day Readmission Following Patient-Directed Discharge in Drug Use-Associated Infective Endocarditis in a National Medicaid Cohort.
    Clin Infect Dis. 2026 Oct 14:ciag649. doi: 10.1093.
    >> Share

  4. WOOD RC, Olson AM, Lochner KA, Dragovich RB, et al
    Tongue Swab Mycobacterium tuberculosis Quantitative Polymerase Chain Reaction for Community Screening of Asymptomatic Tuberculosis Versus Clinic-Based Triage of Symptomatic Tuberculosis.
    Clin Infect Dis. 2026 Oct 9:ciag443. doi: 10.1093.
    >> Share

  5. WEISS ZF, Little JS
    Urinary Antigen Testing for Invasive Aspergillosis: Promise and Remaining Questions.
    Clin Infect Dis. 2026 Oct 8:ciag527. doi: 10.1093.
    >> Share

  6. CHEN R, Li F
    Interpreting Outcomes of Intrathecal Therapy for Tuberculous Meningitis: Treatment Timing, Patient Selection, and Residual Uncertainty.
    Clin Infect Dis. 2026 Oct 7:ciag637. doi: 10.1093.
    >> Share

  7. YILMAZ E, Koker Ozer N, Topal E
    Treatment Timing May Challenge the Apparent Benefit of Intrathecal Therapy in Tuberculous Meningitis.
    Clin Infect Dis. 2026 Oct 7:ciag635. doi: 10.1093.
    >> Share

  8. BABURINA I, Marr KA, Vanbiervliet Y, Permpalung N, et al
    Performance of the Urinary MycoMEIA Aspergillus Assay as an Aid to Diagnose Invasive Aspergillosis.
    Clin Infect Dis. 2026 Oct 7:ciag522. doi: 10.1093.
    >> Share

  9. CUNHA PG, Takahashi MES, Stucchi RSB, Ribeiro MP, et al
    FDG-PET/CT Demonstrates Superior Detection of Multiorgan Involvement in Paracoccidioidomycosis Compared With Conventional Staging.
    Clin Infect Dis. 2026;83:e515-e525.
    >> Share

  10. KAR OB, Freedberg DE
    The Phases of Clostridioides difficile Infection (CDI) in the United States: The History and Epidemiology of CDI From 1935 to Present.
    Clin Infect Dis. 2026;83:401-407.
    >> Share

  11. HIRSCH W, Enns EA, Khoruts A, Rajasingham R, et al
    Cost-effectiveness of Commercial or Traditional Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Clin Infect Dis. 2026;83:391-398.
    >> Share

  12. SMITH AGC, Valentine A, D'Angeli M, Brezak A, et al
    Enhanced Detection of Candidozyma auris Colonization With Universal Screening on Admission.
    Clin Infect Dis. 2026;83:438-441.
    >> Share

  13. HUGHES KRAMER K, Garner W, Clancy CJ, Nguyen MH, et al
    Current State of Knowledge on Medical Cannabis Use and Risk for Infections: A Practical Guide for Clinicians.
    Clin Infect Dis. 2026;83:419-428.
    >> Share

  14. TENFORDE MW, Ujamaa D, Talbot HK, O'Halloran AC, et al
    Prevalence and Outcomes of Bacterial Co-detections by Blood Culture Among Children and Adults Hospitalized With Laboratory-confirmed Influenza, Influenza Hospitalization Surveillance Network, 2022-2024.
    Clin Infect Dis. 2026;83:e641-e649.
    >> Share

  15. LALLJIE A, Budvytiene I, Wheat JL, Theel ES, et al
    Accuracy of Plasma Cell-Free DNA Polymerase Chain Reaction for Diagnosis of Coccidioidomycosis.
    Clin Infect Dis. 2026;83:429-435.
    >> Share

  16. COHEN SH, Allyn P, Chow FC, Rathe J, et al
    Fosmanogepix Treatment for Coccidioidomycosis Under an Expanded Access Program.
    Clin Infect Dis. 2026;83:e526-e529.
    >> Share

  17. PULSIPHER AM, Khattar G, VanDolah H, Gotway M, et al
    Legionella Pneumonia in the Modern Era: Clinical Features and Predictors of Mortality.
    Clin Infect Dis. 2026;83:473-480.
    >> Share

  18. MARQUES AR, Ng SP, McCarthy JE, Telford SR 3rd, et al
    Xenodiagnosis to Search for Borrelia burgdorferi After Antibiotic Treatment of Lyme Disease: A Prospective Cohort Study.
    Clin Infect Dis. 2026;83:e619-e628.
    >> Share

    September 2026

  19. Correction to: Diagnostic and Prognostic Relevance of Valve Strands in Patients With Suspected Infective Endocarditis.
    Clin Infect Dis. 2026 Sep 30:ciag605. doi: 10.1093.
    >> Share


  20. Correction to: The Xpert MTB/RIF Cycle Threshold Value Predicts Mycobacterium tuberculosis Transmission to Close Contacts in a Brazilian Prospective Multicenter Cohort.
    Clin Infect Dis. 2026 Sep 30:ciag589. doi: 10.1093.
    >> Share


  21. Correction to: Rethinking the Routine: Are Repeat Blood Cultures Necessary After Completion of Infective Endocarditis Treatment?
    Clin Infect Dis. 2026 Sep 29:ciag557. doi: 10.1093.
    >> Share

  22. ZHOU X, Hua Z
    Enterococcal Bacteremia: A Day-4 Decision Requires Day-4 Eligibility.
    Clin Infect Dis. 2026 Sep 26:ciag604. doi: 10.1093.
    >> Share

  23. LI LX, Modlin CE
    Ethical Priorities for Candida auris Screening in Solid Organ Transplantation.
    Clin Infect Dis. 2026 Sep 25:ciag536. doi: 10.1093.
    >> Share

  24. SELEMON A, Fernandes ML, Romanowski K, Melnychuk L, et al
    Safety of tuberculosis preventive treatment among people receiving or about to initiate immunosuppressive medications: a systematic review and meta-analysis.
    Clin Infect Dis. 2026 Sep 21:ciag584. doi: 10.1093.
    >> Share

  25. RAJENDRAN P, Pai M
    Non-invasive options for pediatric tuberculosis diagnosis: the search continues.
    Clin Infect Dis. 2026 Sep 18:ciag574. doi: 10.1093.
    >> Share

  26. CLARK DC, Banerjee J, Baden R, Coffey C, et al
    Health Economic Analysis of the AMBITION Protocol for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis in the United States.
    Clin Infect Dis. 2026 Sep 17:ciag485. doi: 10.1093.
    >> Share

  27. REED SD, Li Y, Turner NA, Pasquale DK, et al
    Economic Outcomes of Dalbavancin versus Standard Therapy in Staphylococcus aureus Bacteremia in the DOTS Randomized Clinical Trial.
    Clin Infect Dis. 2026 Sep 17:ciag567. doi: 10.1093.
    >> Share

  28. LAWRENCE DS, Jarvis JN
    When the Evidence Aligns: Single-Dose Liposomal Amphotericin B for Cryptococcal Meningitis in High-Income Settings.
    Clin Infect Dis. 2026 Sep 17:ciag487. doi: 10.1093.
    >> Share

  29. ARENDRUP MC, Wiederhold NP
    Antifungal Resistance in Candida auris in India: A Question of Interpretive Criteria.
    Clin Infect Dis. 2026 Sep 9:ciag555. doi: 10.1093.
    >> Share

  30. ROSSOTTI R, Baiguera C, Bernasconi DP, Bana NB, et al
    A Randomized Clinical Trial to Compare Moxifloxacin Versus Azithromycin for the Treatment of Mycoplasma genitalium: The FARTHEST Study.
    Clin Infect Dis. 2026;83:276-284.
    >> Share

  31. WEN SCH, Hardy MJ, Aslan AT, Harris PNA, et al
    Empirical Antibiotic Activity and Outcomes in Pediatric Gram-negative Bloodstream Infections: A Rank-based Composite Outcome Analysis.
    Clin Infect Dis. 2026;83:e282-e290.
    >> Share

  32. GATTI M, De Paola R, Giorgi B, Pea F, et al
    Comparison of Ceftolozane-Tazobactam and Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant/Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2026;83:e270-e281.
    >> Share

  33. MCKENNA L, Frick M, Alarcon-Guizado VA, Davies GR, et al
    When are Uncontrolled Trials in TB Scientifically and Ethically Justified: Borrowing Wisdom From Early AIDS Clinical Trials.
    Clin Infect Dis. 2026;83:e399-e403.
    >> Share

  34. SUBRAMANIAN AK, Java A, Gupta SK, Gupta S, et al
    Strategies to Mitigate Infection Risk in Patients Receiving Complement Inhibitor Therapy.
    Clin Infect Dis. 2026;83:225-233.
    >> Share

    August 2026
  35. TZIMAS G, Monney P, Ianculescu N, Antiochos P, et al
    Should valve leaflet thickening be considered a characteristic lesion of infective endocarditis?
    Clin Infect Dis. 2026 Aug 30:ciag524. doi: 10.1093.
    >> Share

  36. XU B, Sanaka K
    Nuanced Diagnosis of Infective Endocarditis: When Isolated Valve Leaflet Thickening on Cardiac Imaging is Inadequate for Diagnosis of Infective Endocarditis.
    Clin Infect Dis. 2026 Aug 29:ciag528. doi: 10.1093.
    >> Share

  37. ZUNIGA-MOYA JC, Araujo de Oliveira Santana M, Ostrosky-Zeichner L, Thompson GR 3rd, et al
    Reanalyzing a Randomized Controlled Trial of Invasive Aspergillosis Using a Desirability of Outcome Ranking Approach: Voriconazole Versus Amphotericin B Deoxycholate.
    Clin Infect Dis. 2026 Aug 26:ciag457. doi: 10.1093.
    >> Share

  38. CACHERA L, Miot O, Brousse X, Ternacle J, et al
    Infective Endocarditis in Solid Organ and Haematopoietic Stem Cell Transplant Recipients (E-IPA Study): a propensity-score-matched retrospective cohort study.
    Clin Infect Dis. 2026 Aug 21:ciag507. doi: 10.1093.
    >> Share

  39. ZAZUETA OE, Becerra MC, Galea JT, Calderon RI, et al
    The Impact of Isoniazid Preventive Therapy on Tuberculosis Infection and Disease Progression.
    Clin Infect Dis. 2026 Aug 17:ciag483. doi: 10.1093.
    >> Share


  40. Correction to: The TSwaY Study Network, Diagnostic Yield of Tongue Swab- Compared to Sputum-Based Molecular Testing for Tuberculosis in Four High-Burden Countries.
    Clin Infect Dis. 2026 Aug 4:ciag455. doi: 10.1093.
    >> Share


  41. Correction to: Skipping to Conclusions: Is 1 Negative Follow-up Blood Culture Sufficient in Staphylococcus aureus Bacteremia?
    Clin Infect Dis. 2026 Aug 3:ciag469. doi: 10.1093.
    >> Share

    July 2026

  42. Correction to: Pregnant Women With Multidrug-Resistant/Rifampicin-Resistant Tuberculosis and the All-Oral 6-Month Regimen: Experiences From a Patient Series in South Africa.
    Clin Infect Dis. 2026 Jul 25:ciag448. doi: 10.1093.
    >> Share

  43. YOSHIDA H, Adelman MW, Ifiora F, Perez MA, et al
    Utility of Repeating Blood Cultures in Candidemia: Insights From 2 Large Clinical Data Repositories.
    Clin Infect Dis. 2026;83:e105-e108.
    >> Share

  44. DAS S, Singh S, Tawde Y, Spruijtenburg B, et al
    Trends in Antifungal Resistance and Mechanistic Insights Into Azole Resistance in Candida (Candidozyma) auris: A 13-Year Study of a Comprehensive Set of Clinical Isolates From India.
    Clin Infect Dis. 2026;83:89-99.
    >> Share

  45. ISKANDER JK, Haridopolos S
    Making Invisible Illnesses Visible: Recognizing and Responding to Infection-Associated Chronic Conditions.
    Clin Infect Dis. 2026;83:e58-e61.
    >> Share

  46. STEPHENS AV, Thauland TJ, Whitehill GD, Garcia-Lloret MI, et al
    Immunomodulation in the Treatment of Disseminated Coccidioidomycosis.
    Clin Infect Dis. 2026;83:e92-e102.
    >> Share

  47. YAHAV D, Pinto R, Cook D, Davis J, et al
    Duration of Therapy for Pseudomonas aeruginosa Bacteremia-A Post Hoc Subgroup Analysis From the BALANCE Randomized Controlled Trial.
    Clin Infect Dis. 2026;83:41-47.
    >> Share

  48. WINTHROP KL, Flume PA, Khare R, Sriaroon C, et al
    Omadacycline Monotherapy in Nontuberculous Mycobacterial Pulmonary Disease Caused by Mycobacterium abscessus: Results From a Phase 2, Double-blind, Randomized, Placebo-controlled Study.
    Clin Infect Dis. 2026;83:e133-e142.
    >> Share

  49. LU L, Lin T, Li M, Zhao Z, et al
    Nocardia farcinica as a Potential Pathogen Associated With a Clinical Subtype of Kikuchi-Fujimoto Disease.
    Clin Infect Dis. 2026;83:35-40.
    >> Share

  50. NESEMANN JM, Morocho-Alburqueque N, Quincho-Lopez A, Wittberg DM, et al
    Discrepancy Between Active Trachoma and Tests of Chlamydial Infection in Alto Amazonas, Peru.
    Clin Infect Dis. 2026;83:131-138.
    >> Share

  51. TZIMAS G, Monney P, Guery B, Papadimitriou-Olivgeris M, et al
    Valve strands: to be or not to be... infective endocarditis?
    Clin Infect Dis. 2026 Jul 22:ciag451. doi: 10.1093.
    >> Share

  52. SINHA P, Goffin BD, Karoly M, Kumar N, et al
    Incorporating ambient air pollution as a risk factor for tuberculosis mortality in Delhi, India.
    Clin Infect Dis. 2026 Jul 15:ciag424. doi: 10.1093.
    >> Share

  53. MARTIN Y, Tong S
    Skipping to conclusions: Is one negative follow-up blood culture sufficient in Staphylococcus aureus bacteremia?
    Clin Infect Dis. 2026 Jul 15:ciag419. doi: 10.1093.
    >> Share

  54. HENDRIKS MMC, Kamps EHHM, Norberhuis C, Netea MG, et al
    Routine serial follow-up blood cultures after a negative result within 48 hours of methicillin-susceptible Staphylococcus aureus bacteremia: low yield, high cost.
    Clin Infect Dis. 2026 Jul 15:ciag418. doi: 10.1093.
    >> Share

  55. GIANNITSIOTI E
    Valve Strands in Patients With Infective Endocarditis.
    Clin Infect Dis. 2026 Jul 9:ciag377. doi: 10.1093.
    >> Share

  56. BAGHDADI JD, Harris AD, Pineles L, Al-Shanqeeti S, et al
    Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among Inpatients: A Pragmatic, Randomized Trial.
    Clin Infect Dis. 2026;82:954-961.
    >> Share

  57. HOLTY JC, Person MK, Binney S, Cook R, et al
    Clinical Characteristics and Survival of Hospitalized Anthrax Patients with Pleural, Pericardial, or Peritoneal Fluid Collections.
    Clin Infect Dis. 2026;82:e1184-e1193.
    >> Share

  58. GUPTA A, Iordanov R, Auguste A, Van Enk J, et al
    Melioidosis Complicated by Native Valve Endocarditis in a Traveler Returning From Thailand to the United States.
    Clin Infect Dis. 2026;82:e1216-e1221.
    >> Share

  59. MATSUO T, Borgonovo F, Lahr BD, Petri F, et al
    Clinical Manifestations, Long-Term Trends, and Risk Factors for Treatment Failure in Native Vertebral Osteomyelitis: A 26-Year Mayo Clinic Experience.
    Clin Infect Dis. 2026;82:e1171-e1180.
    >> Share

  60. HONDA JR, Wilsey RN, Raulerson CK, Ding LH, et al
    Documenting Environmentally Acquired Mycobacterium intracellulare subsp. chimaera Pulmonary Disease Soon After Bronchiectasis Onset.
    Clin Infect Dis. 2026;82:e1322-e1325.
    >> Share

  61. CROSS GB, Walker HN, Hasan T, Berry C, et al
    We Are Underprepared for Bedaquiline Resistance: A Call for Clinical and Programmatic Readiness.
    Clin Infect Dis. 2026;82:e1326-e1332.
    >> Share

  62. ROSTER KIO, White PJ, Grad YH
    Why Are Gonorrhea Case Rates Declining in the United States? A Research Agenda.
    Clin Infect Dis. 2026;82:1082-1090.
    >> Share

  63. DESTEFANO IM, Fellman CL, Vagnone PMS, Cumming MA, et al
    Human Cases of Carbapenemase-Producing Escherichia coli Linked to Spread Between Animals and the Environment in a Veterinary Facility-Massachusetts, USA, 2023.
    Clin Infect Dis. 2026;82:e1138-e1144.
    >> Share

  64. MUDRIK-ZOHAR H, Ong SWX, Tong SYC, Hornik-Lurie T, et al
    Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.
    Clin Infect Dis. 2026 Jul 3:ciag387. doi: 10.1093.
    >> Share

  65. SHEN E, Algozhin Y, Trevisi L, LaHood A, et al
    Low Post-Treatment Recurrence After a Shortened All-oral Regimen for Pulmonary Rifampicin- or Multidrug-Resistant Tuberculosis in Individuals without Prior Second-Line Drug Exposure in Kazakhstan.
    Clin Infect Dis. 2026 Jul 1:ciag391. doi: 10.1093.
    >> Share

    June 2026
  66. SZVALB AD, Wurster S, Matsuo T, John TM, et al
    10-Year Trends in Attributable and Contributable Mortality of Culture-Positive Invasive Aspergillosis in Patients with Hematologic Malignancies: Have We Reached the "Ceiling Efficacy Effect" of Modern Antifungals?
    Clin Infect Dis. 2026 Jun 29:ciag393. doi: 10.1093.
    >> Share

  67. TZIMAS G, Monney P, Ianculescu N, Antiochos P, et al
    Diagnostic and prognostic relevance of valve strands in patients with suspected infective endocarditis.
    Clin Infect Dis. 2026 Jun 20:ciag376. doi: 10.1093.
    >> Share

  68. SEO JW, Kim DY, Yoon Y, Lyu YS, et al
    Fosfomycin as Oral Transition Therapy Versus Continued Intravenous beta-Lactams for Complicated Urinary Tract Infections Caused by Extended-Spectrum beta-Lactamase-Producing Enterobacterales: A Multicenter, Open-Label, Randomized Controlled Trial.
    Clin Infect Dis. 2026 Jun 18:ciag345. doi: 10.1093.
    >> Share

  69. MOHAN G, Hanrahan CF, Martinez-Amezcua P, Hoffmann CJ, et al
    Multidimensional Poverty and Implementation Reach of Household Contact Tracing for Tuberculosis in South Africa: Analysis of a Randomized Trial.
    Clin Infect Dis. 2026 Jun 17:ciag321. doi: 10.1093.
    >> Share

  70. ROMO M, LaHood A, Mitnick CD, Rich ML, et al
    Comparison of three linezolid management strategies for peripheral neuropathy in multidrug- or rifampicin-resistant tuberculosis treatment: a target trial emulation.
    Clin Infect Dis. 2026 Jun 12:ciag361. doi: 10.1093.
    >> Share

  71. SIDDIQI OK, Jahn B, Rochau U, Walukaga S, et al
    Cost-effectiveness Analysis of Xpert MTB/RIF Ultra for the Diagnosis of HIV-Associated Tuberculous Meningitis.
    Clin Infect Dis. 2026 Jun 9:ciag348. doi: 10.1093.
    >> Share

  72. BAVARO DF, Belati A, Sacchet D, Cilli A, et al
    Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Cephalosporins Plus Daptomycin as Initial Therapy for MRSA Bacteremia: Does a "Hit Hard and Fast" Strategy Improve Outcomes?
    Clin Infect Dis. 2026 Jun 9:ciag228. doi: 10.1093.
    >> Share

  73. HOPKINS J, Tosas-Auguet O, Waithira N, Painter C, et al
    Mortality and Length of Stay Associated With Community-Acquired Escherichia coli and Staphylococcus aureus Bloodstream Infections: An Observational Study in 9 Low- and Middle-Income Countries.
    Clin Infect Dis. 2026 Jun 2:ciag275. doi: 10.1093.
    >> Share

  74. NGUYEN ATK, Paterson DL, Mo Y, Ezure Y, et al
    Efficacy and Safety of Newer Antibiotics Versus Generic Antibiotics for Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Clin Infect Dis. 2026;82.
    >> Share

  75. MANESH A, Aslan AT, Mohan George M, Sulaiman H, et al
    Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the World.
    Clin Infect Dis. 2026;82.
    >> Share

  76. PATERSON DL, Melnick D, Dane A, Goldberger M, et al
    Considerations in Designing Clinical Trials of Novel Antibacterial Agents Using a Superiority Design.
    Clin Infect Dis. 2026;82.
    >> Share

  77. PATERSON DL
    Advancing Clinical Evidence in Infectious Diseases: An Infectious Diseases Clinical Trials Network for Asia, the "Antimicrobial Resistance Hot Zone".
    Clin Infect Dis. 2026;82.
    >> Share

  78. ALIGUI AF, Hor SW, Blanco-Arevalo A, Gupta A, et al
    Challenges to Accessing Newer Antibiotics for Multidrug-resistant Bacterial Infections in Asia: A Literature Review of Multi-Stakeholder Perspectives.
    Clin Infect Dis. 2026;82.
    >> Share

  79. HARDY MJ, Harris PNA, Mo Y, Venkatesh B, et al
    Antibiotic Clinical Trials: A Review of the Past, Present Challenges, and Potential Solutions.
    Clin Infect Dis. 2026;82.
    >> Share

    May 2026
  80. MA Z, Yu X, Yu Y, Wang Y, et al
    Near-point-of-care diagnosis of tuberculosis with LyocartE MTB Assay: a multicentre diagnostic accuracy study.
    Clin Infect Dis. 2026 May 29:ciag342. doi: 10.1093.
    >> Share

  81. FESER M, Maphosa T, Shroufi A, Rangaraj A, et al
    Clinical Impact and Cost-Effectiveness of Improving Access to Cryptococcal Meningitis Diagnostics and Treatment in Malawi.
    Clin Infect Dis. 2026 May 28:ciag270. doi: 10.1093.
    >> Share

  82. VUYYURU SK, Singh U, Das P, Basant S, et al
    Association of Mycobacterium avium paratuberculosis With Crohn's Disease: A Large Multicenter Study From a Tuberculosis-Endemic Region.
    Clin Infect Dis. 2026;82:841-847.
    >> Share

  83. HUANG CC, Tan Q, Becerra MC, Calderon R, et al
    Impact of Diabetes Mellitus in Tuberculosis (TB) Patients on TB Transmission.
    Clin Infect Dis. 2026;82:829-840.
    >> Share

  84. ROBINSON AL, Boyle MG, Hogan PG, Malone SM, et al
    Evaluating Personal and Environmental Decolonization Strategies for Children With Skin and Soft Tissue Infection and Their Households - A Randomized Clinical Trial.
    Clin Infect Dis. 2026;82:868-877.
    >> Share

  85. CHANG VWL, Li Q, Barnes D, Byrne AL, et al
    Three months of weekly rifapentine and isoniazid versus four months of rifampicin for tuberculosis infection: a randomised controlled trial.
    Clin Infect Dis. 2026 May 15:ciag306. doi: 10.1093.
    >> Share

  86. BARRY SE
    Efficacy Is Not Enough: Delivering Tuberculosis Preventive Therapy in the Real World.
    Clin Infect Dis. 2026 May 12:ciag307. doi: 10.1093.
    >> Share

  87. PEREZ MA, Patel KA, Rasmy L, Yoshida H, et al
    Changes in Epidemiology of Candidemia in the United States with a Focus on Candida auris.
    Clin Infect Dis. 2026 May 11:ciag312. doi: 10.1093.
    >> Share

    April 2026
  88. DI BELLA S, Geremia N, Pea F, Zeitlinger M, et al
    When and How to Use Subcutaneous Antibiotics.
    Clin Infect Dis. 2026;82:e662-e673.
    >> Share

  89. BRAGASON HT, Rognvaldsson KG, Hernandez UB, Erlendsdottir H, et al
    Disease Trends and Mortality From Invasive Pneumococcal Disease: A Long-Term Population-Based Study.
    Clin Infect Dis. 2026;82:e652-e661.
    >> Share

  90. MORGAN DJ, AlShanqeeti S, Coffey KC, Baghdadi JD, et al
    Using Generative Artificial Intelligence to Identify Central Line-associated Bloodstream Infections.
    Clin Infect Dis. 2026;82:e773-e780.
    >> Share

  91. MUSUMECI S, Grant R, Sobel J, Cherkaoui A, et al
    Impact of Discontinuation of Contact Precautions on Healthcare-associated Extended Spectrum beta-Lactamase-Producing Escherichia coli in a Large Tertiary Care Hospital: An Interrupted Time-series Analysis.
    Clin Infect Dis. 2026;82:e794-e798.
    >> Share

  92. SARAVOLATZ L, Gandhi TN, Vaughn VM, Ratz D, et al
    Target Trial Emulation of Empiric Antibiotics on Clinical Outcomes in Moderately Immunocompromised Patients Hospitalized With Pneumonia.
    Clin Infect Dis. 2026;82:648-657.
    >> Share

  93. RAMACHANDRAN V, Onukwube Okaro J, Prasad N, Park S, et al
    Epidemiology of Pediatric Invasive Group A Streptococcal Infections in 10 U.S. States, 2004-2023.
    Clin Infect Dis. 2026 Apr 27:ciag284. doi: 10.1093.
    >> Share

  94. BHAVARAJU R, Andrade B, Siminski S, Kim S, et al
    A Narrative Review of the Regional Prospective Observational Research in Tuberculosis International Consortium: Sharing Diverse Data and Specimens in the Fight Against Tuberculosis.
    Clin Infect Dis. 2026;82.
    >> Share

  95. GUPTE AN, Boisson-Walsh A, Huaman MA, Bhavaraju R, et al
    Long-term Sequelae of Pulmonary Tuberculosis: A Narrative Review.
    Clin Infect Dis. 2026;82.
    >> Share

  96. ARAUJO-PEREIRA M, Bhavaraju R, Hatherill M, Gupta A, et al
    From Exposure to Disease: Predicting Tuberculosis Progression.
    Clin Infect Dis. 2026;82.
    >> Share

  97. DUARTE BB, Ellner J, Wright AD, Hatherill M, et al
    Asymptomatic Tuberculosis Across the Disease Spectrum: A Scoping Review of Epidemiology, Diagnosis, and Public Health Implications.
    Clin Infect Dis. 2026;82.
    >> Share

  98. ZHAN S, Liu W, Yang L, Chen Z, et al
    Fixed-Dose Rifapentine-Isoniazid (1HP) for Tuberculosis Preventive Treatment in Chinese Adults: A Prospective Real-World Safety and Pharmacokinetic Study.
    Clin Infect Dis. 2026 Apr 13:ciag247. doi: 10.1093.
    >> Share

  99. GOLD JAW, Benedict K, Lyman M, Toda M, et al
    Candida glabrata emerges as the most common cause of candidemia: analysis of a large hospital-based database, United States, 2016-2024.
    Clin Infect Dis. 2026 Apr 13:ciag252. doi: 10.1093.
    >> Share

  100. LEROUX-ROELS I, Lins M, Surowitz R, Pragalos A, et al
    Immunogenicity and safety of co-administration of adjuvanted respiratory syncytial virus prefusion F protein vaccine with 20-valent pneumococcal conjugate vaccine in adults aged >/=60 years: a randomized, non-inferiority trial.
    Clin Infect Dis. 2026 Apr 13:ciag250. doi: 10.1093.
    >> Share

    March 2026
  101. YANG Y
    When IS900 Positivity is not the Tie-Breaker: Interpreting Mycobacterium avium Subspecies paratuberculosis Signals Across Crohn's Disease and Intestinal Tuberculosis in a Tuberculosis-Endemic Setting.
    Clin Infect Dis. 2026 Mar 27:ciag127. doi: 10.1093.
    >> Share

  102. MENZA TW, Berzkalns A, Cannon CA, Balkus J, et al
    The population-level impact of doxycycline post-exposure prophylaxis on syphilis in King County, WA: an interrupted time series analysis.
    Clin Infect Dis. 2026 Mar 26:ciag209. doi: 10.1093.
    >> Share

  103. VISEK C, Dalmat RR, Nalutaaya A, Erisa KC, et al
    Prevalence and Predictors of Tuberculosis in Adults and Adolescents With Sputum Trace Ultra Results in 2 High-Burden Clinical Settings.
    Clin Infect Dis. 2026 Mar 20:ciag019. doi: 10.1093.
    >> Share

  104. THWAITES GE
    Targeting Inflammation in Tuberculous Meningitis Treatment.
    Clin Infect Dis. 2026 Mar 20:ciaf574. doi: 10.1093.
    >> Share

  105. KUMAR D SS, Somarkutty N, Prasad D JH, Gautam P, et al
    Role of Low-Dose Infliximab for Inflammatory Complications of Central Nervous System Tuberculosis: A Retrospective Cohort Study.
    Clin Infect Dis. 2026 Mar 20:ciaf573. doi: 10.1093.
    >> Share

  106. RAUTEMAA-RICHARDSON R, Sobel JD, Stone N, De Seta F, et al
    State-of-the-Art Review: Managing Vulvovaginal Candidiasis.
    Clin Infect Dis. 2026;82:371-382.
    >> Share

  107. SIVASUBRAMANIAN G
    Valley Fever in Central California: Diagnosis is Not the Finish Line, the Real Gap is Longitudinal Care.
    Clin Infect Dis. 2026;82:e497-e502.
    >> Share

  108. HATZL S, Kriegl L, Geiger C, Wilhelmer C, et al
    Empirical Antifungal Treatment of Critically ? Patients With Influenza-Associated Acute Respiratory Distress Syndrome: A Propensity Score Weighted Observational Study.
    Clin Infect Dis. 2026;82:e485-e493.
    >> Share

  109. BOUILLER K, Cella E, Jacko NF, Hiehle ME, et al
    Comparing Clinical, Microbiological, and Genetic Definitions of Relapse in Patients With Subsequent Episodes of Methicillin-resistant Staphylococcus aureus Bone and Joint Infection.
    Clin Infect Dis. 2026;82:402-410.
    >> Share

  110. FRATONI AJ, Gethers ML, Nicolau DP, Kuti JL, et al
    Non-Klebsiella pneumoniae Carbapenemase Attributes of the Newer beta-lactam/beta-lactamase Inhibitors, Part 2: Burkholderia cepacia Complex, Stenotrophomonas maltophilia, and Acinetobacter baumannii.
    Clin Infect Dis. 2026;82:411-419.
    >> Share

  111. LIAO H, Hollingsworth BD, Cassidy CA, Zychowski D, et al
    Completion of Paired Serological Testing Algorithms for Spotted Fever Rickettsiosis and Ehrlichiosis, North Carolina: 2017-2020.
    Clin Infect Dis. 2026;82:548-555.
    >> Share

  112. KATRAGADDA S, Yetmar ZA, Chesdachai S, Fida M, et al
    Trends in Anaplasmosis Over the Past Decade: A Review of Clinical Features, Laboratory Data, and Outcomes.
    Clin Infect Dis. 2026;82:539-547.
    >> Share

  113. ITO AS, Reasoner KC, Ong'uti SK, Qian ET, et al
    Evaluation of the impact of universal mupirocin decolonization in intensive care units on the utility of MRSA PCR nasal swab testing.
    Clin Infect Dis. 2026 Mar 16:ciag183. doi: 10.1093.
    >> Share

  114. KHADER K, Haroldsen C, Stevens V, Visnovsky L, et al
    Estimating changes in facility MRSA infection rates due to changes in MRSA precaution policy.
    Clin Infect Dis. 2026 Mar 13:ciag176. doi: 10.1093.
    >> Share

  115. VARGAS DA, Fuertes-Bucheli JF, Sanchez-Hidalgo A, Palomares Velosa J, et al
    Diagnostic Accuracy of Molecular Testing on Saliva and Oral Swabs for Pulmonary Tuberculosis.
    Clin Infect Dis. 2026 Mar 12:ciag055. doi: 10.1093.
    >> Share

  116. KOSENKO M, Davtian L, Iakovleva E, Ashurov M, et al
    Shorter Antitubercular Regimens Versus 9 Months of Isoniazid for Latent Tuberculosis in Children: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2026 Mar 10:ciag073. doi: 10.1093.
    >> Share

  117. MOE CA, Luswata RK, Barrameda AJ, Le H, et al
    Diagnostic Yield of Tongue Swab- Compared to Sputum-Based Molecular Testing for Tuberculosis in Four High-Burden Countries.
    Clin Infect Dis. 2026 Mar 10:ciag077. doi: 10.1093.
    >> Share

  118. ATHAN E, Greenberg RN, Baker DA, Shah R, et al
    Safety, Efficacy, and Immunogenicity of a Multivalent Adjuvanted S. aureus Vaccine in Adults with Recent Skin And Soft Tissue Infections: An Observer-blind, Randomized, Placebo-controlled, Multinational Phase 1/2 Trial.
    Clin Infect Dis. 2026 Mar 9:ciag162. doi: 10.1093.
    >> Share

  119. YANG E, Van Brantegem P, Peloquin CA, Brooks MB, et al
    Pharmacokinetic and pharmacogenomic predictors of hepatotoxicity in the HIRIF trial for drug-susceptible tuberculosis.
    Clin Infect Dis. 2026 Mar 6:ciag141. doi: 10.1093.
    >> Share

  120. MACKOW NA, Shao W, Ge L, Komarow L, et al
    Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections.
    Clin Infect Dis. 2026 Mar 6:ciag160. doi: 10.1093.
    >> Share

    February 2026
  121. APRIANI L, Sidhu H, Korobitsyn A, Ismail N, et al
    Diagnostic Performance of New Commercial IGRAs for Mycobacterium tuberculosis Infection: An updated Systematic Review and Meta-analysis.
    Clin Infect Dis. 2026 Feb 25:ciag102. doi: 10.1093.
    >> Share

  122. SILLAT MS, Chacko G, Jennifer L
    Intracranial Lesion in a Patient With Chronic Myeloid Leukemia.
    Clin Infect Dis. 2026;82:354-357.
    >> Share

  123. ALLAN-BLITZ LT, Klausner JD
    A Rapid Test to Differentiate Viral From Bacterial Infections: Searching for the Holy Grail.
    Clin Infect Dis. 2026;82:215-218.
    >> Share

  124. CROWDER R, Thangakunam B, Andama A, Christopher DJ, et al
    Diagnostic Accuracy of Tuberculosis Screening Tests in a Prospective Multinational Cohort: Chest Radiography With Computer-Aided Detection, Xpert Tuberculosis Host Response, and C-Reactive Protein.
    Clin Infect Dis. 2026;82:e239-e247.
    >> Share

  125. CANTON R, Lim AN, Cortes V, Diaz-Reganon J, et al
    Uncomplicated Urinary Tract Infections: From an Invisible Impact to a Visible Change in Complex Care.
    Clin Infect Dis. 2026 Feb 25:ciaf705. doi: 10.1093.
    >> Share

  126. CRUMPLER M, Realegeno SE, Shakir SM, Hutton SM, et al
    Review of the Performance of Laboratory-Based Molecular Diagnostics for Chlamydia trachomatis and Neisseria gonorrhoeae.
    Clin Infect Dis. 2026;82.
    >> Share

  127. MANABE YC, Smith AC, Trow S, Tran A, et al
    Point-of-care Tests for Chlamydia trachomatis and Neisseria gonorrhoeae: Review of the Literature.
    Clin Infect Dis. 2026;82.
    >> Share

  128. MITCHELL KK, Smith AC, Ayala JC, Schmerer MW, et al
    Review of Methods for Detecting Antimicrobial Resistance of Neisseria gonorrhoeae.
    Clin Infect Dis. 2026;82.
    >> Share

  129. STERKEL AK, Loya TJ, Smith AC, Southern T, et al
    Narrative Review of Chlamydia trachomatis Culture, Viability Testing, and Sequencing Methods.
    Clin Infect Dis. 2026;82.
    >> Share

  130. SOGE OO, Reimche JL, Smith AC, Schmerer MW, et al
    Culture and Identification of Neisseria gonorrhoeae: A Narrative Review of Current Laboratory Methods.
    Clin Infect Dis. 2026;82.
    >> Share

  131. SMITH AC, Kersh EN
    Evidence Review for Centers for Disease Control and Prevention Guidance Development on the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
    Clin Infect Dis. 2026;82.
    >> Share

  132. CONTOU D, Painvin B, Daubin D, Orieux A, et al
    Invasive Meningococcal Disease In Adults Aged >/=65 Years Admitted To French Intensive Care Units: A Nationwide Comparison With Younger Adults.
    Clin Infect Dis. 2026 Feb 24:ciag133. doi: 10.1093.
    >> Share

  133. PUGSLEY RA, Davis NL, Cope AB, Diesel JC, et al
    Is three really what we need? Relative effectiveness of benzathine penicillin G and doxycycline treatment regimens for late or unknown duration syphilis in 6 United States jurisdictions, 2016-2021.
    Clin Infect Dis. 2026 Feb 23:ciag099. doi: 10.1093.
    >> Share

  134. CHEN R, Shen Y, Liu H, Wang M, et al
    Intrathecal Isoniazid and Dexamethasone Therapy May Improve Outcomes in Patients with Tuberculous Meningitis: A Two-Center Retrospective Cohort Study.
    Clin Infect Dis. 2026 Feb 18:ciag106. doi: 10.1093.
    >> Share

  135. BARSHAK MB, Linder JA, Watson ME Jr, Wessels MR, et al
    Overview of 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal (GAS) Pharyngitis: Risk assessment using clinical scoring systems in children and adults.
    Clin Infect Dis. 2026 Feb 14:ciag098. doi: 10.1093.
    >> Share

  136. CAMPBELL JI, Brooks MB, Dankovchik J, Giebultowicz S, et al
    Uncovering household tuberculosis infection testing and care patterns using a novel bioinformatics linkage strategy.
    Clin Infect Dis. 2026 Feb 11:ciag079. doi: 10.1093.
    >> Share

  137. KUHLIN J, Stadler JAM, Grint DJ, Court R, et al
    Treatment adherence with an oral nine-month regimen for rifampicin-resistant tuberculosis in South Africa.
    Clin Infect Dis. 2026 Feb 9:ciag069. doi: 10.1093.
    >> Share

  138. SIRAJ DS, Hollnagel F
    Questioning Non-inferiority: Methodological Concerns in the Meta-analysis of Oral vs. Intravenous Therapy for Staphylococcus aureus Bacteremia.
    Clin Infect Dis. 2026 Feb 9:ciag070. doi: 10.1093.
    >> Share

  139. WANG Y, Li R, Cai L, Jin L, et al
    Accuracy of rapid quantitative PCR on tongue swabs for pulmonary tuberculosis in sputum-scarce patients: a prospective multicentre diagnostic study.
    Clin Infect Dis. 2026 Feb 9:ciag071. doi: 10.1093.
    >> Share

  140. KULKARNI PA, Cortes-Penfield NW, Brehm TJ, Wagenlehner F, et al
    State-of-the-Art Review: Diagnosis and Management of Acute and Chronic Bacterial Prostatitis.
    Clin Infect Dis. 2026;82:1-13.
    >> Share

  141. DORAZIO AJ, Aitken SL, Pierce VM, Kline EG, et al
    First Report of Treatment-Emergent Resistance to Cefepime-Zidebactam in Pseudomonas aeruginosa.
    Clin Infect Dis. 2026;82:44-48.
    >> Share

  142. DOUSA KM, Shin E, Kurz SG, Rubin EJ, et al
    The Role of beta-Lactam Antibiotics in Treating Mycobacterium abscessus: From Laboratory Insights to Clinical Applications and the Case for Clinical Trials.
    Clin Infect Dis. 2026;82:e135-e145.
    >> Share

  143. GRINT DJ, Dhillon J, Butcher PD, Adams J, et al
    Xpert MTB/RIF Cycle Threshold as a Marker of Tuberculosis (TB) Disease Severity: Implications for TB Treatment Stratification.
    Clin Infect Dis. 2026;82:e126-e134.
    >> Share

  144. DE NOOY A, Omar SV, Ockhuisen T, Zwerling A, et al
    Cost-effectiveness of Targeted Next-Generation Sequencing for Tuberculosis Drug-resistance Testing as an Alternative to the Standard of Care in South Africa.
    Clin Infect Dis. 2026;82:e119-e125.
    >> Share

  145. LODISE TP, Garey KW, Aram JA, Nathanson BH, et al
    Association Between Duration of Candidemia and Clinical and Healthcare Resource Utilization Outcomes Among Hospitalized Adult Patients With Candidemia Who Received Empiric Treatment With an Echinocandin Across United States Hospitals.
    Clin Infect Dis. 2026;82:75-85.
    >> Share

  146. ANGELINO NF, O'Hara LM, Bahr M, Newman M, et al
    Patient Perspectives Regarding Different Contact Precaution Policies for Methicillin-resistant Staphylococcus aureus Across Two Hospitals: Patients Are in Favor of Contact Precautions.
    Clin Infect Dis. 2026;82:142-144.
    >> Share

  147. CLARK SA, Heymer E, Campbell H, Ribeiro S, et al
    Clinical and Microbiological Characteristics of Meningococcal Eye Infections: Retrospective National Surveillance in England, 2010-2022.
    Clin Infect Dis. 2026;82:e9-e16.
    >> Share

  148. MULLIS CE, Bishop D, Fazzari M, Tappen N, et al
    Development and Evaluation of a Novel Algorithm to Identify Doxycycline Postexposure Prophylaxis Users at a Large Healthcare System in the Bronx, New York.
    Clin Infect Dis. 2026;82:173-176.
    >> Share

  149. MISHRIKY F, Chan PA
    Antimicrobial resistance concerns should not limit doxycycline post-exposure prophylaxis implementation for bacterial STI prevention.
    Clin Infect Dis. 2026 Feb 9:ciag075. doi: 10.1093.
    >> Share

  150. SOLERA JT, Aparicio-Minguijon E, Dominguez-Perez L, Munoz P, et al
    Baseline Antithrombotic Therapy and Intracranial Hemorrhage Risk in Infective Endocarditis: A Multicenter Prospective Cohort Study.
    Clin Infect Dis. 2026 Feb 6:ciag067. doi: 10.1093.
    >> Share

  151. FLORES JM, Rochat R, Stafford IA, Heiselman C, et al
    State-of-the-Art Review: Congenital Syphilis in the Modern Era: Current Strategies and Future Directions.
    Clin Infect Dis. 2026;81:1023-1035.
    >> Share

  152. BROWN L, Hoa NT, Ly VT, Li L, et al
    Recent Advances in the Diagnosis of Talaromycosis.
    Clin Infect Dis. 2026;81:e533-e543.
    >> Share

  153. WANG C, LaBere BA, Chinga MML, Harris AJ, et al
    Interferon-gamma Therapy in Patients With Refractory Disseminated Coccidioidomycosis.
    Clin Infect Dis. 2026;81:e544-e547.
    >> Share

  154. BAKER AW, La Hoz RM, Anesi JA, Kwon JH, et al
    Epidemiology of Healthcare Facility-Associated Nontuberculous Mycobacteria From 2012 Through 2020 in a 10-Hospital Network in the United States.
    Clin Infect Dis. 2026;81:1106-1114.
    >> Share

  155. BENEDICT K, Hennessee I, Smith DJ, Toda M, et al
    Impact of Fluconazole on Outcomes of Patients With Primary Pulmonary Coccidioidomycosis: A Commercial Health Insurance Claims-based, Propensity Score Matched Analysis.
    Clin Infect Dis. 2026;81:e515-e522.
    >> Share

  156. FALLY M, Bastrup Israelsen S, Benfield T, Tarp B, et al
    The Impact of Lower Respiratory Tract Sample Cultures on Outcomes in Community-Acquired Pneumonia: A Propensity Score-Matched Cohort Study.
    Clin Infect Dis. 2026;81:1152-1158.
    >> Share

  157. SOLOVYEVA AV, Volchenkov GV, Ponomarenko OI, Kuznezova TA, et al
    Implementing a Program of Comprehensive Tuberculosis Preventive Treatment: Safety, Effectiveness, and Acceptability of Moxifloxacin or Bedaquiline Use for Contacts Exposed to Drug-Resistant Strains.
    Clin Infect Dis. 2026 Feb 3:ciaf701. doi: 10.1093.
    >> Share

    January 2026
  158. MANZOOR F, Rhee C, Baker MA, Klompas M, et al
    Mycobacterium tuberculosis Transmission in Healthcare Settings: A Systematic Review of Frequency, Risk Factors, and Exposure Conditions.
    Clin Infect Dis. 2026 Jan 30:ciag053. doi: 10.1093.
    >> Share

  159. LOVEDAY M, Clarence E, Hlangu S, Singh N, et al
    Pregnant women with MDR/RR-TB and the all-oral 6-month regimen: experiences from a patient series in South Africa.
    Clin Infect Dis. 2026 Jan 22:ciag032. doi: 10.1093.
    >> Share

  160. STARKE S, Thomas K, Jasuja S, Lubelchek R, et al
    Short-Course Tuberculosis Preventive Therapy in a High Migration Setting: Early Experience With 1HP in Cook County, Illinois.
    Clin Infect Dis. 2026 Jan 21:ciaf723. doi: 10.1093.
    >> Share

  161. SWEETSER B, Nguyen H, Dang H, Katumba D, et al
    Evaluating the Cepheid Xpert TB/LTBI research-use-only assay for detection of active and latent Mycobacterium tuberculosis infection.
    Clin Infect Dis. 2026 Jan 21:ciag005. doi: 10.1093.
    >> Share

  162. NEOH CF, Chen SC, Morris AJ, Heath CH, et al
    Current Epidemiology and Infection Characteristics of Non-Aspergillus Mold Infections: A Multicenter Study in Australia and New Zealand.
    Clin Infect Dis. 2026 Jan 21:ciag029. doi: 10.1093.
    >> Share

  163. GOTO M, Bandyopadhyay A, Shi Q, Wang Y, et al
    Personalized Antibiogram: A Novel Multi-Task Machine Learning Framework for Simultaneous Prediction of Antimicrobial Resistance Profile with Enhanced Detection of Carbapenem Resistance in Enterobacteriaceae.
    Clin Infect Dis. 2026 Jan 17:ciag027. doi: 10.1093.
    >> Share

  164. ARNOLD SR, Spec A, Baddley JW, Pappas P, et al
    2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Asymptomatic Histoplasma Pulmonary Nodules (Histoplasmomas) and Mild or Moderate Acute Pulmonary Histoplasmosis in Adults, Children,
    Clin Infect Dis. 2026;81.
    >> Share

  165. PAPPAS P, Lentz RJ, Stover KR, Wiederhold NP, et al
    2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Mild or Moderate Acute Pulmonary Histoplasmosis in Adults, Children, and Pregnant People.
    Clin Infect Dis. 2026;81.
    >> Share

  166. BADDLEY JW, Wolf J, Ardura MI, Badreldin N, et al
    2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Asymptomatic Histoplasma Pulmonary Nodules (Histoplasmomas) in Adults, Children, and Pregnant People.
    Clin Infect Dis. 2026;81.
    >> Share

  167. NIWARD K, Braian C, Svardhagen G, Augustinsson D, et al
    Future Prospects for Using Clinical Phenotypes in Tuberculosis Precision Medicine-An Approach for Clinical Management.
    Clin Infect Dis. 2026 Jan 15:ciaf663. doi: 10.1093.
    >> Share

  168. NALUGWA T, Shah KM, Marcelo D, Nakawunde R, et al
    Predicted Preferences for Tuberculosis Point-of-Care Tests among Tuberculosis-Affected Individuals in Five High Burden Countries.
    Clin Infect Dis. 2026 Jan 14:ciag022. doi: 10.1093.
    >> Share


  169. Correction to: Treatment Outcomes With an Oral Short Course Regimen for Rifampicin-resistant Tuberculosis in a High HIV Prevalence, Programmatic Setting in South Africa.
    Clin Infect Dis. 2026 Jan 9:ciaf711. doi: 10.1093.
    >> Share

  170. ADAMSON PC, David HM, Pham LQ, Bui HTM, et al
    Cefixime for the Treatment of Neisseria gonorrhoeae Infections in a Setting With Increased Antimicrobial Resistance: A Retrospective Study in Hanoi, Vietnam.
    Clin Infect Dis. 2026;81.
    >> Share

  171. KLINE MC, Oliveira Roster K, Helekal D, Rumpler E, et al
    Comparing Strategies to Introduce Two New Antibiotics for Gonorrhea: A Modeling Study.
    Clin Infect Dis. 2026;81.
    >> Share

  172. FAGAN L, Alexander S, Fifer H
    The Invisible Tide of Neisseria gonorrhoeae Treatment Failures: A Review and Commentary.
    Clin Infect Dis. 2026;81.
    >> Share

  173. HSU KK, Ivanof C, Gallagher MC, Worrall DP, et al
    How Public Health Surveillance Systems Can Contribute to Antimicrobial Resistance Prevention: The Massachusetts Experience.
    Clin Infect Dis. 2026;81.
    >> Share

  174. VAN DER VEEN S, Sun X, Ge H, Chau TM, et al
    PenA Alleles Associated With Gonococcal Ceftriaxone Resistance in Cambodia, China, and Vietnam.
    Clin Infect Dis. 2026;81.
    >> Share

  175. MELENDEZ JH, Manabe YC
    Current and Emerging Approaches and Technologies for Rapid Detection of Neisseria gonorrhoeae Antimicrobial Resistance.
    Clin Infect Dis. 2026;81.
    >> Share

  176. DAI B, Engen N, Skipper CP, Abassi M, et al
    Evaluating Desirability of Outcome Ranking (DOOR) and Win Ratio for Hierarchical Composite Endpoints in Cryptococcal Meningitis Trials.
    Clin Infect Dis. 2026 Jan 6:ciaf719. doi: 10.1093.
    >> Share

  177. THU NTM, Brown L, Hawkins O, Bloss K, et al
    Development and Clinical Evaluation of a Novel Talaromyces marneffei Mp1p Lateral Flow Assay for Rapid Diagnosis of Talaromycosis.
    Clin Infect Dis. 2026 Jan 6:ciag004. doi: 10.1093.
    >> Share

    December 2025
  178. STAVROPOULOU E, Epprecht J, Siedentop B, Monney P, et al
    Reassessing the 2023 International Society for Cardiovascular Infectious Diseases Duke clinical criteria for infective endocarditis: Impact of excluding fever and updating diagnostic definitions.
    Clin Infect Dis. 2025 Dec 31:ciaf737. doi: 10.1093.
    >> Share

  179. HAR SHEFI T, Oster Y, Gordon O, Durst R, et al
    Cardiac Manifestations of Mycoplasma pneumoniae Infections: A Cohort Study 2007-2024.
    Clin Infect Dis. 2025;81:e269-e276.
    >> Share

  180. SLOCUM E, Walton MG, Burns S, Rees K, et al
    Nontuberculous Mycobacterium Skin Infections Associated With One Tattoo Studio-Oregon, January-April 2023.
    Clin Infect Dis. 2025;81:e414-e416.
    >> Share

  181. HUGHES KRAMER K, Marino CC, Driscoll E, Cheng S, et al
    Medical Cannabis as the Source of Cryptococcus neoformans Infection.
    Clin Infect Dis. 2025;81:914-916.
    >> Share

  182. FAURE E, Cordier C, Delacoste H, Jeanne M, et al
    Weekly Screening of Circulating Mucorales DNA and Early Treatment in Severely Burned Patients Improves Survival: Real-Life Bi-center Experience in France.
    Clin Infect Dis. 2025;81:907-913.
    >> Share

  183. TANDE AJ, Stevens RW, Ilges D, Lahr BD, et al
    Cumulative Antibiotic Exposure Is Associated With Ceftriaxone Resistance Among Patients With Urinary Source Gram-negative Bloodstream Infection: A Retrospective Cohort Study.
    Clin Infect Dis. 2025;81:871-878.
    >> Share

  184. SALAZAR-AUSTIN N, Cohn S, Nonyane BAS, Mulder C, et al
    Effectiveness of a Home-based Approach to Child Contact Investigation and Tuberculosis Preventive Treatment Management by Community Health Workers in Ethiopia: A Pragmatic Cluster-randomized Trial.
    Clin Infect Dis. 2025;81:e385-e392.
    >> Share

  185. SIM BZ, Mah JK, Heldman MR, Stanly KL, et al
    Plasma Microbial Cell-free DNA Metagenomic Sequencing for Diagnosis of Invasive Fungal Diseases Among High-risk Outpatient and Inpatient Immunocompromised Hosts.
    Clin Infect Dis. 2025;81:1008-1014.
    >> Share

  186. CHASTAIN DB, Thompson GR, Henao-Martinez AF
    Glucocorticoids, Concomitant Immunosuppression, and Pneumocystis jirovecii Pneumonia Prophylaxis Among US Adults.
    Clin Infect Dis. 2025;81:1015-1018.
    >> Share

  187. MBULI C, Jean Bosco TF, Nsamenang R, Nestor B, et al
    Diagnostic performance of the Pluslife MiniDock MTB and Molbio MTB Ultima assays to detect tuberculosis from tongue and sputum swabs among outpatients and in active case finding in Cameroon.
    Clin Infect Dis. 2025 Dec 23:ciaf709. doi: 10.1093.
    >> Share

  188. TRAUTNER BW, Cortes-Penfield NW, Gupta K, Hirsch EB, et al
    Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Duration of Antibiotics for Complicated UTI.
    Clin Infect Dis. 2025 Dec 20:ciaf462. doi: 10.1093.
    >> Share

  189. THOMPSON LA, Gratrix J, Ives N, Fonseca K, et al
    Evaluating the Impact of Implementing and Scaling-Up the Use of Syphilis Rapid/Point-of-Care Tests (RPOCTs): An Interrupted Time Series Analysis of New Syphilis Positivity Rates in Alberta, Canada.
    Clin Infect Dis. 2025 Dec 19:ciaf651. doi: 10.1093.
    >> Share

  190. MARINO AM, Arua E, de Vos L, Fiphaza K, et al
    Hidden in Success: Gendered Patterns of Suboptimal Care Engagement Among TB Patients Who "Successfully" Completed Treatment in South Africa.
    Clin Infect Dis. 2025 Dec 19:ciaf714. doi: 10.1093.
    >> Share

  191. TRAUTNER BW, Cortes-Penfield NW, Gupta K, Hirsch EB, et al
    Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Timing of Intravenous to Oral Antibiotics Transition for Complicated UTI.
    Clin Infect Dis. 2025 Dec 19:ciaf461. doi: 10.1093.
    >> Share

  192. VAN DER WERF TS, Sturkenboom MGG
    One Piece in the Puzzle of Tuberculous Meningitis: Dexamethasone Pharmacokinetics.
    Clin Infect Dis. 2025 Dec 18:ciaf644. doi: 10.1093.
    >> Share

  193. CALDERIN JM, Resendiz-Galvan JE, Abdelgawad N, Davis A, et al
    Pharmacokinetics of Dexamethasone in Tuberculous Meningitis.
    Clin Infect Dis. 2025 Dec 18:ciaf642. doi: 10.1093.
    >> Share

  194. MCCREESH N, MacPherson P, Bampi JVB, Engel N, et al
    Reported Tuberculosis Symptoms: An Inadequate Classifier of Disease State.
    Clin Infect Dis. 2025 Dec 10:ciaf611. doi: 10.1093.
    >> Share

  195. DALE KD
    Why we should move away - not towards - symptom-based terminology and policy in tuberculosis.
    Clin Infect Dis. 2025 Dec 5:ciaf667. doi: 10.1093.
    >> Share

  196. LINDER JA, Watson ME, Wessels MR, Carter DM, et al
    2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal (GAS) Pharyngitis: Risk assessment using clinical scoring systems in children and adults.
    Clin Infect Dis. 2025 Dec 4:ciaf668. doi: 10.1093.
    >> Share

    November 2025
  197. SWETS MC, Bakk Z, Westgeest AC, Ruffin F, et al
    Reproducible identification of Staphylococcus aureus bacteremia clinical subphenotypes.
    Clin Infect Dis. 2025 Nov 27:ciaf655. doi: 10.1093.
    >> Share

  198. NGUYEN HT, Vo LNQ, Codlin AJ, Forse R, et al
    Diagnostic Accuracy of the STANDARD F TB-Feron FIA Assay for Tuberculosis Infection in Vietnam: A Cross-Sectional Study.
    Clin Infect Dis. 2025 Nov 26:ciaf561. doi: 10.1093.
    >> Share

  199. BRITTO C, Cavalli L, Senghore M, McAdam AJ, et al
    A 15-year Single-center Analysis of Late-onset Group B Streptococcus Infection Correlating Clinical Severity With Pathogen Virulence Determinants.
    Clin Infect Dis. 2025 Nov 25:ciaf603. doi: 10.1093.
    >> Share

  200. WALSH TJ, Sicignano D, Mastropietro M, Lovelace B, et al
    Aspergillosis-Attributable Mortality in the United States: Analysis of Death Certificate Data.
    Clin Infect Dis. 2025 Nov 24:ciaf653. doi: 10.1093.
    >> Share

  201. KWAGHE VG, Erameh C, Courtney LP, Samuels JO, et al
    Epidemiology and Clinical Characteristics of Human Rickettsial Infections Detected in Nigeria: Discovery of a Significant Contributor to Acute Febrile Illness.
    Clin Infect Dis. 2025;81.
    >> Share

  202. MURRILL MT, Velasquez GE, Szumowski JD, Phillips A, et al
    Tuberculosis infection screening recommendations for targeted immunotherapies: comparison of U.S. prescribing information, clinical resources and quality measures.
    Clin Infect Dis. 2025 Nov 19:ciaf628. doi: 10.1093.
    >> Share

  203. DESIMONE DC, Baddour LM
    Post Treatment Blood Cultures in Patients with Infective Endocarditis: Valuable, Inconsequential or Worse?
    Clin Infect Dis. 2025 Nov 12:ciaf618. doi: 10.1093.
    >> Share

  204. REGINA J, Ianculescu N, Tzimas G, Monney P, et al
    Rethinking the routine: Are repeat blood cultures necessary after completion of infective endocarditis treatment?
    Clin Infect Dis. 2025 Nov 12:ciaf617. doi: 10.1093.
    >> Share

  205. BERCOT B, Assoumou L, Camelena F, Voitichouk C, et al
    Antimicrobial drug-resistant Neisseria gonorrhoeae (GC) infections in men using doxycycline postexposure prophylaxis. A substudy of the ANRS 174 DOXYVAC trial.
    Clin Infect Dis. 2025 Nov 10:ciaf591. doi: 10.1093.
    >> Share

  206. GEORGE CM, Sanvura P, Namunesha A, Bisimwa JC, et al
    Epidemiology of Vibrio cholerae Infections in the Households of Cholera Patients in the Democratic Republic of the Congo: PICHA7 WASHmobile Prospective Cohort Study.
    Clin Infect Dis. 2025;81:797-805.
    >> Share

  207. GEORGE CM, Sanvura P, Bisimwa JC, Endres K, et al
    Effects of a Water, Sanitation, and Hygiene Program on Diarrhea, Cholera, and Child Growth in the Democratic Republic of the Congo: A Cluster-Randomized Controlled Trial of the Preventative Intervention for Cholera for 7 Days (PICHA7 WASHmobile) Mobil
    Clin Infect Dis. 2025;81:785-796.
    >> Share

  208. MACVANE SH, Moon R, David J, Rosenthal N, et al
    Microbiology Laboratory Testing Practices of Gram-Negative Bloodstream Infections With Difficult-to-Treat Resistant Phenotypes in US Hospitals.
    Clin Infect Dis. 2025;81:710-720.
    >> Share

    October 2025
  209. POUY R, Rallet B, Coutureau C, Hentzien M, et al
    Towards a wider use of oral antibiotic switch in infective endocarditis.
    Clin Infect Dis. 2025 Oct 30:ciaf599. doi: 10.1093.
    >> Share

  210. SUZUKI J, Mizuno T, Takahashi S, Imai H, et al
    Does oral antibiotic switching therapy show similar efficacy to intravenous administration for treating infective endocarditis?
    Clin Infect Dis. 2025 Oct 30:ciaf598. doi: 10.1093.
    >> Share

  211. LOVEDAY M, Hughes J, Mchunu N, Yende-Zuma N, et al
    Maternal, pregnancy and infant outcomes in women treated for multidrug/rifampicin-resistant tuberculosis with novel and repurposed drugs in KwaZulu-Natal, South Africa.
    Clin Infect Dis. 2025 Oct 29:ciaf593. doi: 10.1093.
    >> Share

  212. WIJK M, Denti P, Gausi K, Myers B, et al
    Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment.
    Clin Infect Dis. 2025 Oct 24:ciaf586. doi: 10.1093.
    >> Share

  213. MINGCHAY P, Kawkitinarong K, Torvorapanit P, Ohata PJ, et al
    Effectiveness of Nebulized Bronchodilator - Enhanced Sputum Induction in Thai Patients with Presumed Pulmonary Tuberculosis; A Randomized Controlled Trial; (NeB-TB Trial).
    Clin Infect Dis. 2025 Oct 23:ciaf580. doi: 10.1093.
    >> Share

  214. LI HK, Zhu N, Waddell O, Coelho J, et al
    Mortality Among Patients With Invasive Group A Streptococcal Infections Caused by the M1UK Lineage: A Retrospective Cohort Study in England and Wales.
    Clin Infect Dis. 2025 Oct 16:ciaf492. doi: 10.1093.
    >> Share

  215. MOONAN PK, Buff A, Nandakumar S, Morris Bamrah S, et al
    C-reactive protein in TB meningitis: signal, surrogate, or saboteur?
    Clin Infect Dis. 2025 Oct 16:ciaf575. doi: 10.1093.
    >> Share

  216. TUGUME L, Cresswell FV, Bahr NC, Dai B, et al
    C-reactive protein in TB meningitis: a viable biomarker for individualized care.
    Clin Infect Dis. 2025 Oct 16:ciaf576. doi: 10.1093.
    >> Share

  217. SMITH HJ, Modlin C
    CARB Your Enthusiasm: An Ethics-Informed Analysis for Clinicians of the US National Action Plan for Combating Antibiotic-Resistant Bacteria.
    Clin Infect Dis. 2025 Oct 16:ciaf478. doi: 10.1093.
    >> Share

  218. MULENGA H, Shenje J, Mendelsohn SC, Luabeya AKK, et al
    Asymptomatic Tuberculosis in Children with Household Exposure to Mycobacterium tuberculosis.
    Clin Infect Dis. 2025 Oct 15:ciaf562. doi: 10.1093.
    >> Share

  219. CHEN SC, Lee YT
    Precision Prevention of Tuberculosis in Biologic Therapy: Lessons Beyond Screening Strategies.
    Clin Infect Dis. 2025 Oct 3:ciaf559. doi: 10.1093.
    >> Share

  220. SAUNDERS KE, Charles A, Doyle TJ, Reyes J, et al
    Risk factors associated with progression to clinical Candida auris infection among adults with previous colonization-Florida, 2019-2023.
    Clin Infect Dis. 2025 Oct 2:ciaf551. doi: 10.1093.
    >> Share

    September 2025
  221. RUIZ-TAGLE C, Seguel R, Villarroel L, Bernales M, et al
    Reducing Household Tuberculosis Transmission: A Pilot Cluster-Randomized Controlled Trial.
    Clin Infect Dis. 2025 Sep 26:ciaf526. doi: 10.1093.
    >> Share

  222. CHEN SC, Chen CC
    Reassessing Adherence Trajectories in Multidrug-Resistant Tuberculosis: Recovery Advantage and Hidden Biases.
    Clin Infect Dis. 2025 Sep 25:ciaf536. doi: 10.1093.
    >> Share

  223. BROOKS MB, Lecca L, Becerra MC, Calderon RI, et al
    The Role of Youths in Within-Household Tuberculosis Transmission: A Household Contact Cohort Study.
    Clin Infect Dis. 2025 Sep 24:ciaf490. doi: 10.1093.
    >> Share

  224. WALLS G, McGrath L, Herdman MT, Campbell AJ, et al
    Patient-reported perceptions, experiences and preferences around intravenous and oral antibiotics for the treatment of Staphylococcus aureus bacteremia: a descriptive qualitative study.
    Clin Infect Dis. 2025 Sep 24:ciaf522. doi: 10.1093.
    >> Share

  225. TAWEESUK A, Rattanaumpawan P, Rachakhom S, Wangchinda W, et al
    Cluster-randomized Controlled Trial of Enhanced Carbapenem-resistant Enterobacterales Prevention Program in General Medicine Wards, Siriraj Hospital.
    Clin Infect Dis. 2025 Sep 22:ciaf523. doi: 10.1093.
    >> Share

  226. LEOCADIO C, Garcia E, Lash M, Berardi J, et al
    Clinical Outcomes of Mpox Disease in Patients Treated with Tecovirimat.
    Clin Infect Dis. 2025 Sep 19:ciaf520. doi: 10.1093.
    >> Share

  227. OLESEN RH, Larsen EB, Rubak T, Baunwall SMD, et al
    Cost-Effectiveness of Hospital-at-Home and Fecal Microbiota Transplantation in Treating Older Patients With Clostridioides difficile.
    Clin Infect Dis. 2025;81:348-354.
    >> Share

  228. LEE G, Hollingsworth BD, Giandomenico DA, Fisher TG, et al
    Impact of Revised Diagnostic Testing Algorithms and Case Definitions on Lyme Disease Surveillance in a Low-Incidence State: An Interrupted Time Series Analysis.
    Clin Infect Dis. 2025;81:403-406.
    >> Share

  229. PEREZ-RECIO S, Grijota-Camino MD, Guardiola J, Juanola X, et al
    Prevention of Tuberculosis in Patients Treated With Biological Therapies: Twenty Years' Experience in a Specialised Tuberculosis Clinic in a Low-prevalence Country.
    Clin Infect Dis. 2025 Sep 5:ciaf491. doi: 10.1093.
    >> Share

  230. ARRIAGA MB, Amorim G, Figueiredo MC, Staats C, et al
    Body Mass Index and Incident Tuberculosis in Close Tuberculosis Contacts.
    Clin Infect Dis. 2025 Sep 3:ciaf475. doi: 10.1093.
    >> Share

  231. SEIBERT AM, Matheu M, Buckel WR, Bledsoe J, et al
    Increasing HIV Testing During Gonorrhea and Chlamydia Evaluations in Urgent Care and Emergency Departments: A Large Health System Initiative.
    Clin Infect Dis. 2025 Sep 1:ciaf434. doi: 10.1093.
    >> Share

    August 2025
  232. LAW S, Fulcher I, Ashraf S, Bastard M, et al
    Characterizing treatment adherence trajectories in the endTB multisite cohort of drug-resistant tuberculosis patients: an application of group-based trajectory modelling.
    Clin Infect Dis. 2025 Aug 22:ciaf467. doi: 10.1093.
    >> Share

  233. POORE H, Wambi P, Nkereuwem E, Nakafeero J, et al
    The three-gene Xpert Host Response signature for pediatric tuberculosis screening: A prospective diagnostic accuracy study.
    Clin Infect Dis. 2025 Aug 21:ciaf445. doi: 10.1093.
    >> Share

  234. SINHA P, Bhargava M, Dauphinais MR, Carwile ME, et al
    In-kind Nutritional Supplementation for Persons With Drug-susceptible Tuberculosis and Their Household Contacts Would be Cost-effective for Reducing Tuberculosis Incidence and Mortality in Jharkhand, India: A Modeling Study.
    Clin Infect Dis. 2025 Aug 20:ciaf400. doi: 10.1093.
    >> Share

  235. RALLET B, Pouy R, Coutureau C, Blot M, et al
    Should we extend the use of oral antibiotics in infective endocarditis? The ENDO-ORAL study.
    Clin Infect Dis. 2025 Aug 18:ciaf452. doi: 10.1093.
    >> Share

  236. BISIMWA BC, Kiselinova M, Cuella I, Rigouts L, et al
    Retrospective Cohort Analysis for Identification of Discordant Rifampicin-resistant Xpert MTB/RIF Assay Results in South Kivu, Eastern Democratic Republic of the Congo, a High Burden Tuberculosis Setting.
    Clin Infect Dis. 2025 Aug 12:ciaf451. doi: 10.1093.
    >> Share

  237. KHALIL S, Sohail MR
    Timing is Everything: Integrating Time to Blood Culture Positivity in Predicting Risk of Endocarditis in Patients with Staphylococcus aureus Bacteremia.
    Clin Infect Dis. 2025 Aug 12:ciaf447. doi: 10.1093.
    >> Share

  238. RUTAKINGIRWA MK, Skipper CP, Dai B, Wele A, et al
    Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical Trial.
    Clin Infect Dis. 2025 Aug 7:ciaf432. doi: 10.1093.
    >> Share

  239. CHURCHYARD GJ, Swindells S, Gupta A, Shah NS, et al
    Preventing multidrug resistant tuberculosis: the dawn of a new era.
    Clin Infect Dis. 2025 Aug 7:ciaf426. doi: 10.1093.
    >> Share

  240. SUTTON KN, Lydon E, Rader A, Barton KD, et al
    A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Acute Bacterial Skin and Skin Structure Infections.
    Clin Infect Dis. 2025;81.
    >> Share

  241. RUFFIN F, Sutton KN, Miller J, Lane H, et al
    A Qualitative Secondary Analysis of Patient Health-Related Quality of Life in Bloodstream Infections by Source: Intra-abdominal, Urinary Tract, and Acute Bacterial Skin and Skin Structure Infection.
    Clin Infect Dis. 2025;81.
    >> Share

  242. KRAH NM, Fai C, Sutton KN, Rader A, et al
    A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia.
    Clin Infect Dis. 2025;81.
    >> Share

  243. HOWARD-ANDERSON J, Doernberg SB, Dixon D, Gopinath R, et al
    Interagency Collaboration for Patient-Centered Antibacterial Drug Development.
    Clin Infect Dis. 2025;81.
    >> Share

  244. YAN M, Hernandez A, Chan KK, Stanbrook MB, et al
    Population-Based Analysis of the Risk of Mycobacterial Infections Associated With Immune Checkpoint Inhibitors.
    Clin Infect Dis. 2025;81:176-178.
    >> Share

  245. CHELI S, Torre A, Schiuma M, Montrasio C, et al
    NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study.
    Clin Infect Dis. 2025;81:145-152.
    >> Share

    July 2025
  246. MURRAY MB, Madden AE, Ofori SK
    Harmonization of Study Design and Reporting for Chronic Pulmonary Aspergillosis in Tuberculosis Patients.
    Clin Infect Dis. 2025 Jul 30:ciaf309. doi: 10.1093.
    >> Share

  247. BEZUIDENHOUT C, Long L, Nichols B, Meyer-Rath G, et al
    Sputum and tongue swab molecular testing for the in-home diagnosis of tuberculosis in unselected household contacts: a cost and cost-effectiveness analysis.
    Clin Infect Dis. 2025 Jul 24:ciaf389. doi: 10.1093.
    >> Share

  248. SMITH DJ, Misas E, Gold JAW, Evert N, et al
    Fungal meningitis in U.S. Patients who Received Epidural Anesthesia in Matamoros, Mexico.
    Clin Infect Dis. 2025 Jul 22:ciaf399. doi: 10.1093.
    >> Share

  249. LIU W, He T, Zhan S, Qin H, et al
    Safety, feasibility and rifapentine plasma concentration in Chinese children with 1 month of daily rifapentine plus isoniazid for tuberculosis infection.
    Clin Infect Dis. 2025 Jul 21:ciaf404. doi: 10.1093.
    >> Share

  250. HURALSKA M, Pogue JM, Rybak M, Abdul-Mutakabbir JC, et al
    The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of Patients With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative Pathogens.
    Clin Infect Dis. 2025 Jul 19:ciaf398. doi: 10.1093.
    >> Share

  251. ROCKMAN L, Abdulgader SM, Minnies S, Palmer Z, et al
    Oral washes and tongue swabs for Xpert MTB/RIF Ultra-based tuberculosis diagnosis in people with and without the ability to make sputum.
    Clin Infect Dis. 2025 Jul 18:ciaf397. doi: 10.1093.
    >> Share

  252. ANDREWS JR, Kendall EA, Cattamanchi A, Denkinger CM, et al
    Projecting the impact and costs of near point-of-care tuberculosis screening assays in community-based active case finding.
    Clin Infect Dis. 2025 Jul 17:ciaf395. doi: 10.1093.
    >> Share

  253. ESCRIHUELA-VIDAL F, Ong SWX, Oriol I, Grillo S, et al
    Adjunctive Fosfomycin for the Treatment of Staphylococcus aureus Bacteremia: A Pooled Post-hoc Analysis of Individual Participant Data from Two Randomized Trials.
    Clin Infect Dis. 2025 Jul 16:ciaf387. doi: 10.1093.
    >> Share

  254. LOPEZ LF, Arenas S, Jimenez A, Ferreira TBD, et al
    Improved consistency of Candida auris colonization screening with an anterior nares and hands composite sample.
    Clin Infect Dis. 2025 Jul 10:ciaf365. doi: 10.1093.
    >> Share

  255. WANG B, Giles L, Andraweera P, McMillan M, et al
    Long-term protection against invasive meningococcal B disease and gonococcal infection five years after implementation of funded childhood and adolescent 4CMenB vaccination program in South Australia: an observational cohort and case-control study.
    Clin Infect Dis. 2025 Jul 10:ciaf372. doi: 10.1093.
    >> Share

  256. MACLEAN EL, Pham YN, Pham CD, Nguyen BC, et al
    Long-term outcomes among people with multi-drug resistant tuberculosis in Vietnam: a prospective cohort study.
    Clin Infect Dis. 2025 Jul 9:ciaf363. doi: 10.1093.
    >> Share

  257. LI Y, Zhang Y, Song L, Cai C, et al
    A Short, All-Oral Regimen for Pre-Extensively Drug-Resistant Tuberculosis: A Multicenter Open-label Single-arm Study.
    Clin Infect Dis. 2025 Jul 8:ciaf351. doi: 10.1093.
    >> Share

  258. COX SR, Moe AH, Gupte AN, Kadam A, et al
    A point-of-care prediction tool for recurrent tuberculosis.
    Clin Infect Dis. 2025 Jul 8:ciaf353. doi: 10.1093.
    >> Share

  259. SANTOS-PATARROYO SD, Saleh OA, Chesdachai S, Lahr BD, et al
    Blood Culture Time to Positivity and Risk of Infective Endocarditis.
    Clin Infect Dis. 2025 Jul 4:ciaf359. doi: 10.1093.
    >> Share

  260. STROMDAHL M, Ursing J
    Time to positivity in Staphylococcus aureus bacteremia - one of many pieces in the diagnostic puzzle.
    Clin Infect Dis. 2025 Jul 4:ciaf360. doi: 10.1093.
    >> Share

  261. TONIZZO A, Munoz P, Burillo A, Adan I, et al
    Is Time to Positivity in Staphylococcus aureus Bacteremia a Harbinger of Endocarditis?
    Clin Infect Dis. 2025 Jul 4:ciaf358. doi: 10.1093.
    >> Share

    June 2025
  262. TUGUME L, Cresswell FV, Engen NW, Tukundane A, et al
    Prognostic Value of C-Reactive Protein in Adults With Tuberculous Meningitis: A Prospective Cohort Study.
    Clin Infect Dis. 2025 Jun 24:ciaf261. doi: 10.1093.
    >> Share

  263. MOYO M, Jarvis JN
    ART Management in Cryptococcal Meningitis.
    Clin Infect Dis. 2025 Jun 24:ciaf227. doi: 10.1093.
    >> Share

  264. PATAMATAMKUL S
    Should ART Be Interrupted in Recently Initiated Persons With Recently Diagnosed HIV-Associated Cryptococcal Meningitis?
    Clin Infect Dis. 2025 Jun 24:ciaf226. doi: 10.1093.
    >> Share

  265. BUSSINI L, Bavaro DF, Brunetta E, Carella F, et al
    What is the impact of anti-enterococcal empirical therapy on survival of patients with enterococcal bloodstream infections?
    Clin Infect Dis. 2025 Jun 18:ciaf323. doi: 10.1093.
    >> Share

  266. PAPADIMITRIOU-OLIVGERIS M, Guery B
    Redefining complicated coagulase negative staphylococcal bacteremia.
    Clin Infect Dis. 2025 Jun 18:ciaf308. doi: 10.1093.
    >> Share

  267. VARISCO B, Rodriguez-Bano J, Lopez-Cortes LE
    Toward defining complicated coagulase-negative staphylococcal bacteremia.
    Clin Infect Dis. 2025 Jun 18:ciaf307. doi: 10.1093.
    >> Share

  268. LU X, Jiang Y, Zhang R, Zhang Y, et al
    Epidemiologic and Bacterial Factors Facilitating Long-Term Transmission of Multidrug-Resistant Tuberculosis in Shanghai, China.
    Clin Infect Dis. 2025 Jun 18:ciaf313. doi: 10.1093.
    >> Share

  269. AGARWAL R, Nyendak M, Chava N, Allam RR, et al
    Long-term protection from TB preventive treatment among people with HIV in a high-burden tuberculosis setting: an observational cohort study from India.
    Clin Infect Dis. 2025 Jun 16:ciaf322. doi: 10.1093.
    >> Share

  270. SHAPIRO L, Henao-Martinez AF
    Letter to the Editor: Re-evaluating Immune-Based Strategies for Cryptococcal Meningitis in Non-HIV Populations.
    Clin Infect Dis. 2025 Jun 16:ciaf326. doi: 10.1093.
    >> Share

  271. KURLAND S, Furebring M, Lowdin E, Olaison L, et al
    Antifungal therapy in Candida infective endocarditis: a comparison of echinocandins and other treatment regimens in a nation-wide cohort study.
    Clin Infect Dis. 2025 Jun 14:ciaf312. doi: 10.1093.
    >> Share

  272. JOHNSON KA, Fernando R, Plotzker R, Burghardt NO, et al
    Characteristics Associated with Disseminated Gonococcal Infections vs Uncomplicated Gonorrhea: A California Case-Control Study, 2021-2022.
    Clin Infect Dis. 2025 Jun 10:ciaf311. doi: 10.1093.
    >> Share

  273. REDMOND SN, Cadnum JL, Jencson AL, Kaple CE, et al
    Emergence and Spread of Clostridioides difficile Isolates With Reduced Fidaxomicin Susceptibility in an Acute Care Hospital.
    Clin Infect Dis. 2025;80:984-991.
    >> Share

  274. BAGHDADI JD, Goodman KE, Magder LS, Claeys KC, et al
    Association Between Delayed Broad-Spectrum Gram-negative Antibiotics and Clinical Outcomes: How Much Does Getting It Right With Empiric Antibiotics Matter?
    Clin Infect Dis. 2025;80:949-958.
    >> Share

  275. TURNER NA, Grambow SC, Polage C, Kuhar DT, et al
    Natural History of Clostridioides difficile-Related Disease Progression in the 2-Step Testing Era.
    Clin Infect Dis. 2025;80:975-983.
    >> Share

  276. LIEU A, Zimmet AN, Pozdol J, Kushner LE, et al
    Concordance of Noninvasive Plasma Cell-free DNA With Invasive Diagnostics for Diagnosis of Invasive Fungal Disease.
    Clin Infect Dis. 2025;80:1095-1102.
    >> Share

  277. GALANIS E, MacDougall L, Rose C, Chen SCA, et al
    Predictors of Cryptococcus gattii Clinical Presentation and Outcome: An International Study.
    Clin Infect Dis. 2025;80:1088-1094.
    >> Share

  278. JAGANATH D, Nabeta P, Nicol MP, Castro R, et al
    Stool processing methods for Xpert Ultra testing in childhood tuberculosis: A prospective, multi-country accuracy study.
    Clin Infect Dis. 2025 Jun 3:ciaf289. doi: 10.1093.
    >> Share

  279. DE JAGER V, Mockeliunas L, You H, Simonsson USH, et al
    A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination with Meropenem plus Amoxicillin/Clavulanate Among Adults with Rifampicin-Resistant Pulmonary Tuberculosis.
    Clin Infect Dis. 2025 Jun 2:ciaf276. doi: 10.1093.
    >> Share

    May 2025
  280. POWERS LA, Chan AK, Wattengel BA, Davis M, et al
    Secondary Pneumococcal Disease in Veterans with Viral Respiratory Infections.
    Clin Infect Dis. 2025 May 31:ciaf285. doi: 10.1093.
    >> Share

  281. PURCHASE SE, Brigden J, Seddon JA, Martinson NA, et al
    Risk of tuberculosis infection in young children exposed to multidrug-resistant tuberculosis in the TB-CHAMP multi-site randomised controlled trial.
    Clin Infect Dis. 2025 May 29:ciaf284. doi: 10.1093.
    >> Share

  282. BONGOMIN F, Denning DW
    Pulmonary Tuberculosis Associated Chronic Pulmonary Aspergillosis: Urgent Need to Standardize Reporting of Prevalence Studies.
    Clin Infect Dis. 2025 May 28:ciaf279. doi: 10.1093.
    >> Share


  283. Correction to: Serial Mass Screening for Tuberculosis Among Incarcerated Persons in Brazil.
    Clin Infect Dis. 2025 May 21:ciaf223. doi: 10.1093.
    >> Share

  284. BALBUENA JP, Cordova E, Mykietiuk A, Farina J, et al
    Carbapenem-resistant Gram-negative bacilli bacteremia in Argentina (EMBARCAR): findings from a prospective, multicenter cohort study.
    Clin Infect Dis. 2025 May 20:ciaf259. doi: 10.1093.
    >> Share

  285. REGAN JJ, Wang Z, Phares CR
    The Effect of Live-Virus Vaccines on Tests for Tuberculosis Infection During the US Immigration Medical Examination: Are Vaccines Causing False-Negative Results?
    Clin Infect Dis. 2025 May 15:ciaf129. doi: 10.1093.
    >> Share

  286. BROWN KA, Fridman DJ, Garber GE, Johnstone J, et al
    The Burden of Antimicrobial Resistant Bacteremia in Ontario: A Population-wide Analysis of Attributable Mortality from 110 Pathogen-Antibiotic Combinations.
    Clin Infect Dis. 2025 May 13:ciaf213. doi: 10.1093.
    >> Share

  287. CHEVALIER JM, Hansen MA, Blumel B, Chuchu V, et al
    Modeling the impact and cost of a culture-dependent molecular test for antimicrobial resistance in resource-limited settings.
    Clin Infect Dis. 2025 May 12:ciaf236. doi: 10.1093.
    >> Share

  288. STADLER JAM, Kuhlin JJ, Molloy SF, Mtwa NN, et al
    Treatment Outcomes With an Oral Short Course Regimen for Rifampicin-resistant Tuberculosis in a High HIV Prevalence, Programmatic Setting in South Africa.
    Clin Infect Dis. 2025 May 9:ciaf112. doi: 10.1093.
    >> Share

  289. CHIANG SS, Campbell JR, Pelissari DM, de Oliveira MCB, et al
    The Impact of Pregnancy on Tuberculosis Treatment Outcomes: An Analysis of Brazilian National Surveillance Data 2016-2022.
    Clin Infect Dis. 2025 May 6:ciaf233. doi: 10.1093.
    >> Share

  290. SPINELLI MA, Heise MJ, Roman J, Bena J, et al
    Sustained Effectiveness of Doxycycline Post-Exposure-Prophylaxis in a Large Sexual Health Clinic over 96 Weeks: An Interrupted Time Series Analysis.
    Clin Infect Dis. 2025 May 6:ciaf234. doi: 10.1093.
    >> Share

    April 2025
  291. YETMAR ZA, Marty PK, Clement J, Miranda C, et al
    State-of-the-Art Review: Modern Approach to Nocardiosis-Diagnosis, Management, and Uncertainties.
    Clin Infect Dis. 2025;80:e53-e64.
    >> Share

  292. MANOHARAN-BASIL S, Vanbaelen T, Kenyon C
    Evidence for selection of doxycycline resistance in Staphylococcus aureus in DoxyPrEP study.
    Clin Infect Dis. 2025 Apr 30:ciaf219. doi: 10.1093.
    >> Share

  293. MARKLEY JD, Bajaj JS
    Rethinking Antibiotic Prophylaxis for Spontaneous Bacterial Peritonitis in Patients With Cirrhosis: First, Do No Harm.
    Clin Infect Dis. 2025;80:710-714.
    >> Share

  294. LANGFORD BJ, Brown KA, Lau C, Calzavara A, et al
    Evaluating Harms Associated With Prolonged Antibiotic Duration of Therapy in Community-Dwelling Older Adults: A Cohort Study Using Instrumental Variable Analysis.
    Clin Infect Dis. 2025;80:715-722.
    >> Share

  295. ALLEN C, Deanehan JK, Dotan Y, Eisenberg MA, et al
    Development of a Reference Standard to Assign Bacterial Versus Viral Infection Etiology Using an All-inclusive Methodology for Comparison of Novel Diagnostic Tool Performance.
    Clin Infect Dis. 2025;80:735-743.
    >> Share

  296. LI C, Zhu DP, Chen J, Zhu XY, et al
    Invasive Fungal Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in China: A Multicenter Epidemiological Study (CAESAR 2.0).
    Clin Infect Dis. 2025;80:807-816.
    >> Share

  297. PAPADIMITRIOU-OLIVGERIS M, Ledergerber B, Siedentop B, Monney P, et al
    Beyond the Timeline: 1-Year Mortality Trends in Early Versus Late Prosthetic Valve Endocarditis.
    Clin Infect Dis. 2025;80:804-806.
    >> Share

  298. LARSSON L, Calderwood CJ, Marambire ET, Held K, et al
    Body mass index trajectories and association with tuberculosis risk in a cohort of household contacts in Southern Africa.
    Clin Infect Dis. 2025 Apr 28:ciaf222. doi: 10.1093.
    >> Share

  299. DAHL VN, Pedersen OS, Butova T, Kuzhko M, et al
    Effectiveness of the BPaL(M) Regimen for Drug-Resistant Tuberculosis in Ukraine under Programmatic Conditions.
    Clin Infect Dis. 2025 Apr 25:ciaf214. doi: 10.1093.
    >> Share

  300. YOON H, Pirofski LA, Boulware DR
    Cryptococcal Meningitis Treatment Beyond HIV: Recognizing the need for Individualized Immune-Based Strategies.
    Clin Infect Dis. 2025 Apr 25:ciaf218. doi: 10.1093.
    >> Share

  301. BIRABAHARAN M
    Vancomycin-Resistant Enterococci-Active Perioperative Prophylaxis for Liver Transplant Patients Requires Attention to the Gut Microbiota.
    Clin Infect Dis. 2025 Apr 22:ciaf168. doi: 10.1093.
    >> Share

  302. KIM S, Pelissari DM, Harada LO, Sanchez M, et al
    Long-term mortality trends among individuals with tuberculosis: a retrospective cohort study of individuals diagnosed with tuberculosis in Brazil.
    Clin Infect Dis. 2025 Apr 18:ciaf206. doi: 10.1093.
    >> Share

  303. SUTHERLAND JS, van der Spuy GD, Shaw JA, Richardson T, et al
    Performance of 2 Finger-Stick Blood Tests to Triage Adults With Symptoms of Pulmonary Tuberculosis: A Prospective Multisite Diagnostic Accuracy Study.
    Clin Infect Dis. 2025 Apr 16:ciaf105. doi: 10.1093.
    >> Share

  304. CHESDACHAI S, DeSimone DC, Ranganath N, Abu Saleh OM, et al
    Plasma Quantitative Microbial Cell-Free DNA for Staphylococcal Cardiac Implantable Electronic Device Infection - Too Soon?
    Clin Infect Dis. 2025 Apr 15:ciaf195. doi: 10.1093.
    >> Share

  305. KARCHMER AW, Park SY, Zimetbaum PJ
    Diagnosing Staphylococcal Cardiac Electronic Implantable Device Endocarditis: The Potential of Quantitative Plasma Cell-Free Microbial DNA.
    Clin Infect Dis. 2025 Apr 15:ciaf196. doi: 10.1093.
    >> Share

  306. HODGES MR, Tawadrous M, Cornely OA, Thompson GR 3rd, et al
    Fosmanogepix for the Treatment of Invasive Mold Diseases Caused by Aspergillus Species and Rare Molds: A Phase 2, Open-Label Study (AEGIS).
    Clin Infect Dis. 2025 Apr 9:ciaf185. doi: 10.1093.
    >> Share


  307. Correction to: Bedaquiline Resistance and Treatment Outcomes Among Patients With Tuberculosis Previously Exposed to Bedaquiline in India: A Multicentric Retrospective Cohort Study.
    Clin Infect Dis. 2025 Apr 4:ciaf174. doi: 10.1093.
    >> Share

  308. GOEHRINGER F, Soudant M, Alauzet C, Selton-Suty C, et al
    Single- versus multiple-sampling strategy for blood cultures in the diagnosis of infective endocarditis: the prospective multicenter UniEndo study.
    Clin Infect Dis. 2025 Apr 3:ciaf163. doi: 10.1093.
    >> Share

  309. STEAD D, Wasserman S, Steenkamp E, Parrish A, et al
    Comparative Performance of Urine Lipoarabinomannan and Urine Xpert MTB/RIF Ultra for Diagnosing Tuberculosis in Adult Inpatients With Human Immunodeficiency Virus in East London, South Africa.
    Clin Infect Dis. 2025 Apr 2:ciaf080. doi: 10.1093.
    >> Share

    March 2025
  310. BARTL L, Zeeb M, Kalin M, Loosli T, et al
    Machine Learning-Based Prediction of Active Tuberculosis in People with HIV using Clinical Data.
    Clin Infect Dis. 2025 Mar 25:ciaf149. doi: 10.1093.
    >> Share

  311. ADZEMOVIC T, Nalintya E, Fieberg A, Mande E, et al
    Diagnostic Accuracy of the Updated FujiLAM II Assay to Detect Tuberculosis in Outpatients With Advanced HIV Disease.
    Clin Infect Dis. 2025 Mar 25:ciaf079. doi: 10.1093.
    >> Share

  312. PRODANUK M, Silverberg SL, Piche-Renaud PP, Farrar DS, et al
    Adverse events of first-line therapy for pediatric tuberculosis: A systematic review and meta-analysis.
    Clin Infect Dis. 2025 Mar 24:ciaf152. doi: 10.1093.
    >> Share

  313. CUELLA-MARTIN I, Hakizayezu F, Ahmed A, Runyambo D, et al
    Paucibacillary tuberculosis drives the low positive predictive value of Xpert MTB/RIF Ultra for rifampicin resistance detection in low-prevalence settings.
    Clin Infect Dis. 2025 Mar 22:ciaf132. doi: 10.1093.
    >> Share

  314. MADDEN A, Ofori SK, Budu M, Sisay E, et al
    A systematic review of chronic pulmonary aspergillosis among patients treated for pulmonary tuberculosis.
    Clin Infect Dis. 2025 Mar 21:ciaf150. doi: 10.1093.
    >> Share

  315. BRUNEL AS, Seydoux C, Schmidt S, Ahlyege S, et al
    Epidemiology, Risk Factors and Outcome of Neutropenic Enterocolitis in Onco-Hematological Patients according to Chemotherapy Regimen.
    Clin Infect Dis. 2025 Mar 20:ciaf134. doi: 10.1093.
    >> Share

  316. SODEKE O, Shah NS, Pals S, Riabokon S, et al
    Lower Tuberculosis Incidence Among People With Human Immunodeficiency Virus Who Completed Isoniazid Preventive Therapy in Ukraine, a High-Burden Multidrug-Resistant Tuberculosis Setting: A Retrospective Cohort Study.
    Clin Infect Dis. 2025 Mar 18:ciaf069. doi: 10.1093.
    >> Share

  317. TALA-IGHIL T, Garcia-Hermoso D, Dalle F, Cassaing S, et al
    Epidemiology and Prognostic Factors Associated With Mold-Positive Blood Cultures: 10-Year Data From a French Prospective Surveillance Program (2012-2022).
    Clin Infect Dis. 2025;80:529-539.
    >> Share

  318. KIM JY, Hwang H, Yim D, Choi Y, et al
    Relationship Between Clarithromycin Minimum Inhibitory Concentrations and Treatment Responses in Mycobacterium avium Complex Pulmonary Disease.
    Clin Infect Dis. 2025;80:637-643.
    >> Share

  319. MATOGA MM, Chen JS, Sena AC, Ndalama B, et al
    High prevalence of Haemophilus ducreyi among patients with suspected primary syphilis in Malawi, 2019-2022.
    Clin Infect Dis. 2025 Mar 17:ciaf114. doi: 10.1093.
    >> Share

  320. BURASTERO GJ, Wey EQ, Guidetti V, Cantergiani S, et al
    Impact of VRE-active perioperative prophylaxis in liver transplant patients colonized by Vancomycin-Resistant Enterococci.
    Clin Infect Dis. 2025 Mar 14:ciaf121. doi: 10.1093.
    >> Share

  321. SINGLA R, Khan S, Silsarma A, Chavan V, et al
    Bedaquiline Resistance and Treatment Outcomes Among Patients With Tuberculosis Previously Exposed to Bedaquiline in India: A Multicentric Retrospective Cohort Study.
    Clin Infect Dis. 2025 Mar 13:ciaf068. doi: 10.1093.
    >> Share

  322. PAPADIMITRIOU-OLIVGERIS M, Senn L, Guery B
    Validation of the proposed definition for complicated coagulase negative staphylococcal bacteremia.
    Clin Infect Dis. 2025 Mar 13:ciaf119. doi: 10.1093.
    >> Share

  323. KARCHMER AW, Kaufman NJ, Park SY, Modi RM, et al
    Quantitative Microbial Cell-Free DNA Sequencing from Plasma: A Potential Biomarker for the Diagnosis of Staphylococcal Infection of Cardiac Implantable Electronic Devices.
    Clin Infect Dis. 2025 Mar 11:ciaf113. doi: 10.1093.
    >> Share

    February 2025
  324. SOGE OO, Thibault CS, Cannon CA, McLaughlin SE, et al
    Potential Impact of Doxycycline Post-Exposure Prophylaxis on Tetracycline Resistance in Neisseria gonorrhoeae and Colonization with Tetracycline-Resistant Staphylococcus aureus and Group A Streptococcus.
    Clin Infect Dis. 2025 Feb 28:ciaf089. doi: 10.1093.
    >> Share

  325. NGUYEN MH, Daley CL
    Chronic Pulmonary Aspergillosis and Nontuberculous Mycobacterial Pulmonary Disease: Two Peas in a Pod.
    Clin Infect Dis. 2025 Feb 28:ciaf091. doi: 10.1093.
    >> Share

  326. DENNING DW, Kosmidis C
    Chronic pulmonary aspergillosis is a differential diagnosis and co-infection with Nontuberculous Mycobacterial Pulmonary Disease.
    Clin Infect Dis. 2025 Feb 28:ciaf090. doi: 10.1093.
    >> Share

  327. JASWAL MR, Martinez L, Brooks M, Farooq S, et al
    Tuberculosis preventive treatment for household contacts at health facility and community settings in Pakistan.
    Clin Infect Dis. 2025 Feb 27:ciaf088. doi: 10.1093.
    >> Share

  328. SWARTWOOD NA, Cohen T, Marks SM, Hill AN, et al
    Effects of the COVID-19 pandemic on TB outcomes in the United States: a Bayesian analysis.
    Clin Infect Dis. 2025 Feb 27:ciaf092. doi: 10.1093.
    >> Share

  329. STEFANOVIC A, Alam ME, Matic N, Larnder A, et al
    Increased Severity of Multidrug-Resistant Shigella sonnei Infections in People Experiencing Homelessness.
    Clin Infect Dis. 2025;80:339-346.
    >> Share

  330. HENNESSEE I, Palmer S, Reik R, Miles-Jay A, et al
    Epidemiological and Clinical Features of a Large Blastomycosis Outbreak at a Paper Mill in Michigan.
    Clin Infect Dis. 2025;80:356-363.
    >> Share

  331. HAGMAN K, Nilsson AC, Hedenstierna M, Ursing J, et al
    Outcomes of Adjunctive Corticosteroid Treatment in Hypoxemic Adults Hospitalized for Mycoplasma pneumoniae Pneumonia: A Retrospective Cohort Study.
    Clin Infect Dis. 2025;80:454-460.
    >> Share

  332. HENNESSEE I, Benedict K, Bahr NC, Lipner SR, et al
    Incidence and Risk Factors for Invasive Fungal Infections in Patients Initiating Tumor Necrosis Factor-Alpha Inhibitors for Inflammatory Bowel Disease and Rheumatoid Arthritis.
    Clin Infect Dis. 2025;80:364-366.
    >> Share

  333. GARCIA R, Septimus EJ, LeDonne J, Sturm LK, et al
    Prevention of Vascular Access Device-Associated Hospital-Onset Bacteremia and Fungemia: A Review of Emerging Perspectives and Synthesis of Technical Aspects.
    Clin Infect Dis. 2025;80:444-450.
    >> Share

  334. HSU AJ, Chiotos K, Heil EL, Shields RK, et al
    The Effectiveness of Newer Beta-Lactams for the Treatment of Antimicrobial-Resistant Gram-Negative Meningitis.
    Clin Infect Dis. 2025 Feb 20:ciaf071. doi: 10.1093.
    >> Share

  335. TZELIOS CA, Malatesta S, Carney T, White LF, et al
    Patient Determinants and Effects on Adherence of Adverse Drug Reactions to Tuberculosis Treatment: A Prospective Cohort Analysis.
    Clin Infect Dis. 2025 Feb 20:ciae642. doi: 10.1093.
    >> Share

  336. SINHA A, Klebe R, Rekart ML, Alvarez JL, et al
    The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)-Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings-A Prospective Cohort Study in Belarus and Uzbekistan.
    Clin Infect Dis. 2025 Feb 18:ciaf035. doi: 10.1093.
    >> Share

  337. MUNSIFF SS
    American Thoracic Society/Centers for Disease Control and Prevention/European Respiratory Society/Infectious Diseases Society of America (ATS/CDC/ERS/IDSA) Updated guideline on the treatment of tuberculosis.
    Clin Infect Dis. 2025 Feb 14:ciaf066. doi: 10.1093.
    >> Share

  338. DREKONJA DM, Shaukat A, Huang Y, Zhang JH, et al
    A Randomized Controlled Trial of Efficacy and Safety of Fecal Microbiota Transplant for Preventing Recurrent Clostridioides difficile Infection.
    Clin Infect Dis. 2025;80:52-60.
    >> Share

  339. ALSHANNAQ AF, Kates AE, Keating JA, Mckinley LL, et al
    Diverse Sources and Latent Reservoirs of Community-Associated Clostridioides difficile Infection.
    Clin Infect Dis. 2025;80:37-42.
    >> Share

  340. FEUERSTADT P, Chopra T, Knapple W, Van Hise NW, et al
    PUNCH CD3-OLS: A Phase 3 Prospective Observational Cohort Study to Evaluate the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA) in Adults With Recurrent Clostridioides difficile Infection.
    Clin Infect Dis. 2025;80:43-51.
    >> Share

  341. SHAH S, Kline EG, Haidar G, Squires KM, et al
    Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant Pseudomonas aeruginosa Bacteremia or Pneumonia.
    Clin Infect Dis. 2025;80:24-28.
    >> Share

    January 2025
  342. MARANCHICK N, Peloquin CA, Haley CA
    Linezolid Dosing and Pharmacokinetics in North American Patients with Tuberculosis.
    Clin Infect Dis. 2025 Jan 21:ciaf027. doi: 10.1093.
    >> Share

  343. VENA A, Tiseo G, Falcone M, Bartalucci C, et al
    Impact of Fluconazole Resistance on the Outcomes of Patients With Candida parapsilosis Bloodstream Infections: A Retrospective Multicenter Study.
    Clin Infect Dis. 2025 Jan 15:ciae603. doi: 10.1093.
    >> Share

  344. MOYO M, Lawrence DS, Jafali J, Molloy SF, et al
    Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in Human Immunodeficiency Virus-associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From Africa.
    Clin Infect Dis. 2025 Jan 15:ciae586. doi: 10.1093.
    >> Share

  345. ESPINOSA-PEREIRO J, Aguiar A, Nara E, Medina A, et al
    Safety, Efficacy and Pharmacokinetics of daily optimised doses of Rifampicin for the Treatment of Tuberculosis: A Systematic Review and Bayesian Network Meta-Analysis.
    Clin Infect Dis. 2025 Jan 10:ciaf003. doi: 10.1093.
    >> Share

  346. ARBIV OA, Holmes T, Kim MJ, Yan M, et al
    Safety of Triple-Dose Rifampin in Tuberculosis Treatment: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2025 Jan 9:ciaf004. doi: 10.1093.
    >> Share

    December 2024
  347. NOLAN T, Bhusal C, Hoberman A, Llapur CJ, et al
    Immunogenicity, Reactogenicity, and Safety of a Pentavalent Meningococcal ABCWY Vaccine in Adolescents and Young Adults who had Previously Received a Meningococcal ACWY Vaccine: Phase 3, Randomized, Controlled Clinical Study.
    Clin Infect Dis. 2024 Dec 26:ciae622. doi: 10.1093.
    >> Share

  348. PLOTKIN SA, Shapiro ED
    The Current and Future State of Vaccines for Lyme Disease.
    Clin Infect Dis. 2024 Dec 23:ciae639. doi: 10.1093.
    >> Share

  349. STROMDAHL M, Hagman K, Hedman K, Westman A, et al
    Time to Staphylococcus aureus Blood Culture Positivity as a risk marker of Infective Endocarditis: A Retrospective Cohort Study.
    Clin Infect Dis. 2024 Dec 21:ciae628. doi: 10.1093.
    >> Share

  350. HATZL S, Geiger C, Kriegl L, Scholz L, et al
    Performance of diagnostic algorithms in patients with invasive pulmonary aspergillosis.
    Clin Infect Dis. 2024 Dec 20:ciae633. doi: 10.1093.
    >> Share

  351. MACPHERSON L, Kik SV, Quartagno M, Lakay F, et al
    Diagnostic Accuracy of Chest X-ray Computer-Aided Detection Software for Detection of Prevalent and Incident Tuberculosis in Household Contacts.
    Clin Infect Dis. 2024 Dec 18:ciae528. doi: 10.1093.
    >> Share

  352. COUSSEMENT J, Heath CH, Roberts MB, Lane RJ, et al
    Management, outcomes and predictors of mortality of Cryptococcus infection in patients without HIV: a multicentre study in 46 hospitals from Australia and New Zealand.
    Clin Infect Dis. 2024 Dec 18:ciae630. doi: 10.1093.
    >> Share

  353. TAI DBG, Patel R, Lovecchio F, Kwee T, et al
    State-of-the-Art Review: Diagnosis and Management of Spinal Implant Infections.
    Clin Infect Dis. 2024;79:e65-e71.
    >> Share

  354. LODISE TP, Bhavnani SM, Ambrose PG, Sader HS, et al
    Piperacillin/Tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations From the United States Committee on Antimicrobial Susceptibility Testing.
    Clin Infect Dis. 2024;79:1354-1362.
    >> Share

  355. DAGAN R, van der Beek BA
    Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine is Reduced in Infants Immunized during the Respiratory Viral Season.
    Clin Infect Dis. 2024 Dec 17:ciae619. doi: 10.1093.
    >> Share

  356. AUMA E, Alberts R, Derendinger B, Venter R, et al
    Diagnostic accuracy of LiquidArray MTB-XDR VER1.0 for the detection of Mycobacterium tuberculosis complex, fluoroquinolone, amikacin, ethambutol, and linezolid susceptibility.
    Clin Infect Dis. 2024 Dec 12:ciae614. doi: 10.1093.
    >> Share

  357. KHAN U, Rich M, Franke M, Lachenal N, et al
    The Frequency and Incidence of QT Prolongation with Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country MDR/RR-TB Cohort.
    Clin Infect Dis. 2024 Dec 10:ciae601. doi: 10.1093.
    >> Share

  358. ZHU Y, Forsman LD, Chen C, Zhang H, et al
    Reply to He et al: Established Association Between Glycemic Control and Anti-Tuberculosis Drug Exposures After Controlling Confounding Effects.
    Clin Infect Dis. 2024 Dec 9:ciae533. doi: 10.1093.
    >> Share

  359. CHEN J, Xie X, Zhang A, He Y, et al
    Is There a Genuine Correlation Between Blood Glucose Control and Anti-tuberculosis Drug Concentrations, or Is it Merely an Illusion?
    Clin Infect Dis. 2024 Dec 9:ciae532. doi: 10.1093.
    >> Share

    November 2024
  360. BUERGLER H, Gregoriano C, Laager R, Mueller B, et al
    Microbiological trends, in-hospital outcomes, and mortality in infective endocarditis: a Swiss-nationwide cohort study.
    Clin Infect Dis. 2024 Nov 27:ciae582. doi: 10.1093.
    >> Share

  361. STAVROPOULOU E, Monney P, Tzimas G, Ianculescu N, et al
    Predictors of persistent fever among patients with suspected infective endocarditis: think outside the box.
    Clin Infect Dis. 2024 Nov 27:ciae588. doi: 10.1093.
    >> Share

  362. BIRCK MG, Moura CS, Winthrop KL, Machado MAA, et al
    Choosing Wisely: Effectiveness and Safety of Antibiotic Prophylaxis in Close Contacts of Invasive Group A Streptococci Infection.
    Clin Infect Dis. 2024 Nov 26:ciae524. doi: 10.1093.
    >> Share

  363. GASOYAN H, Deshpande A, Imrey PB, Guo N, et al
    Potential Implications of Using Locally Validated Risk Factors for Drug-Resistant Pathogens in Patients With Community-Acquired Pneumonia in US Hospitals: A Cross-Sectional Study.
    Clin Infect Dis. 2024;79:1277-1282.
    >> Share

  364. JIMENEZ A, Rosa R, Ayoub S, Guran R, et al
    Factors Associated With Poor Clinical and Microbiologic Outcomes in Candida auris Bloodstream Infection: A Multicenter Retrospective Cohort Study.
    Clin Infect Dis. 2024;79:1262-1268.
    >> Share

  365. RAY MJ, Strnad LC, Tucker KJ, Furuno JP, et al
    Influence of Antibiotic Exposure Intensity on the Risk of Clostridioides difficile Infection.
    Clin Infect Dis. 2024;79:1129-1135.
    >> Share

  366. PUYAT JH, Brode SK, Shulha H, Romanowski K, et al
    Predicting risk of tuberculosis disease in people migrating to a low-TB incidence country: development and validation of a multivariable dynamic risk prediction model using health administrative data.
    Clin Infect Dis. 2024 Nov 20:ciae561. doi: 10.1093.
    >> Share

  367. ROSEN LV, Thielking AM, Dugdale CM, Montepiedra G, et al
    Tuberculosis Preventive Treatment for Pregnant People With Human Immunodeficiency Virus in South Africa: A Modeling Analysis of Clinical Benefits and Risks.
    Clin Infect Dis. 2024 Nov 15:ciae508. doi: 10.1093.
    >> Share

  368. FERRAN E, Chan C, Sheikh N, Dedicoat M, et al
    Population-level frequency of fluoroquinolone resistance by whole-genome sequencing drug predictions in Mycobacterium tuberculosis complex isolates in England from 2017-2023.
    Clin Infect Dis. 2024 Nov 13:ciae560. doi: 10.1093.
    >> Share

  369. PU J, Wu S, He JQ
    Efficacy and Safety of Systematic Corticosteroids treatment among HIV-Positive Patients with Tuberculosis: a systematic review and meta-analysis of randomized controlled trials.
    Clin Infect Dis. 2024 Nov 11:ciae563. doi: 10.1093.
    >> Share

  370. CRITCHLEY JA, Limb ES, Khakharia A, Carey IM, et al
    Tuberculosis and increased incidence of cardiovascular disease: Cohort study using US and UK health records.
    Clin Infect Dis. 2024 Nov 4:ciae538. doi: 10.1093.
    >> Share

    October 2024
  371. DOMBROWSKI JC, Donnell D, Grabow C, Cohen SE, et al
    Evidence-Informed Provision of Doxycycline Post-Exposure Prophylaxis for Prevention of Bacterial Sexually Transmitted Infections.
    Clin Infect Dis. 2024 Oct 30:ciae527. doi: 10.1093.
    >> Share

  372. BROOKS JT, Solans BP, Beranger A, Schaaf HS, et al
    Linezolid Pharmacokinetic-Anemia Modeling in Children with Rifampicin-Resistant Tuberculosis.
    Clin Infect Dis. 2024 Oct 18:ciae497. doi: 10.1093.
    >> Share

  373. NGUYEN MH, Haas MK, Kasperbauer SH, Calado Nogueira de Moura V, et al
    Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects.
    Clin Infect Dis. 2024;79:e27-e47.
    >> Share

  374. NGUYEN MH, Haas MK, Kasperbauer SH, Calado Nogueira de Moura V, et al
    Executive Summary: State-of-the-Art Review: Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects.
    Clin Infect Dis. 2024;79:805-806.
    >> Share

  375. WANG T, Park B, Anderson G, Shaller B, et al
    Application of Diagnostic Stewardship to Fungal Polymerase Chain Reaction: Low Yield of Follow-up Testing on Plasma and Bronchoalveolar Lavage After a Negative Result.
    Clin Infect Dis. 2024;79:944-952.
    >> Share

  376. SELF WH, Johnson KD, Resser JJ, Whitney CG, et al
    Prevalence, Clinical Severity, and Serotype Distribution of Pneumococcal Pneumonia Among Adults Hospitalized With Community-Acquired Pneumonia in Tennessee and Georgia, 2018-2022.
    Clin Infect Dis. 2024;79:838-847.
    >> Share

  377. HORNE M, Woolley I, Lau JSY
    The Use of Long-term Antibiotics for Suppression of Bacterial Infections.
    Clin Infect Dis. 2024;79:848-854.
    >> Share

  378. ONG SWX, Luo J, Fridman DJ, Lee SM, et al
    Association Between Infectious Diseases Consultation and Mortality in Hospitalized Patients With Gram-negative Bloodstream Infection: A Retrospective Population-wide Cohort Study.
    Clin Infect Dis. 2024;79:855-863.
    >> Share

  379. AITKEN SL, Pierce VM, Pogue JM, Kline EG, et al
    The Growing Threat of NDM-Producing Escherichia coli With Penicillin-Binding Protein 3 Mutations in the United States-Is There a Potential Role for Durlobactam?
    Clin Infect Dis. 2024;79:834-837.
    >> Share

  380. NATHAVITHARANA RR, Pearl A, Biewer A, Young L, et al
    Effects of respiratory isolation for tuberculosis to reduce community-based transmission: a systematic review.
    Clin Infect Dis. 2024 Oct 14:ciae496. doi: 10.1093.
    >> Share

  381. MUNRO AP, House T
    Cycles of susceptibility: Immunity debt explains altered infectious disease dynamics post -pandemic.
    Clin Infect Dis. 2024 Oct 11:ciae493. doi: 10.1093.
    >> Share


  382. Correction to: Prosthetic Joint Infections due to Candida Species: A Multicenter International Study.
    Clin Infect Dis. 2024 Oct 10:ciae492. doi: 10.1093.
    >> Share

  383. LAMBERINK H, Huygens S, Aerts R, Lagrou K, et al
    Superiority trials in invasive aspergillosis: a harsh reality check with the IA-DUET (HOVON502) trial.
    Clin Infect Dis. 2024 Oct 8:ciae501. doi: 10.1093.
    >> Share

  384. VIRDEE AK, Knudtzen FC, Llibre JM, Omland LH, et al
    Risk of tuberculosis after achieving HIV virological suppression on antiretroviral therapy: a Danish nationwide prospective cohort study.
    Clin Infect Dis. 2024 Oct 8:ciae499. doi: 10.1093.
    >> Share

  385. PATAMATAMKUL S
    Implications of Undiagnosed Subclinical Cryptococcal Meningitis in Clinically Asymptomatic Low-Titer Cryptococcal Antigenemia Among PLWH: More Questions to Answer.
    Clin Infect Dis. 2024 Oct 8:ciae507. doi: 10.1093.
    >> Share

  386. YANG YC, Chen BS, Dong C, Wei JC, et al
    Correspondence to Otogenic Meningitis Surgery Outcome Study.
    Clin Infect Dis. 2024 Oct 7:ciae503. doi: 10.1093.
    >> Share

    September 2024
  387. WEN SCH, Harris PNA, Forde B, Permana B, et al
    Characterization of Gram-negative Bloodstream Infections in Hospitalized Australian Children and Their Clinical Outcomes.
    Clin Infect Dis. 2024;79:734-743.
    >> Share

  388. DUDOIGNON E, Chevret S, Tsague S, Hamane S, et al
    Risk Factors and Outcome Associated With Fungal Infections in Patients With Severe Burn Injury: 10-year Retrospective IFI-BURN Study.
    Clin Infect Dis. 2024;79:682-689.
    >> Share

  389. SMITH DJ, Thompson GR 3rd, Baddley JW, Pappas PG, et al
    Clinical Testing Guidance for Histoplasmosis in Patients With Community-acquired Pneumonia for Primary and Urgent Care Providers: Commentary on Enzyme Immunoassay Histoplasma Antibody Testing.
    Clin Infect Dis. 2024;79:797-798.
    >> Share

  390. CHRISTENSON JC, Barros N, Kirkpatrick L, Schneider JG, et al
    Clinical Testing Guidance for Histoplasmosis in Patients With Community-Acquired Pneumonia for Primary and Urgent Care Providers: Role of Enzyme Immunoassay Histoplasma-Specific Immunoglobulin G and Immunoglobulin M Testing.
    Clin Infect Dis. 2024;79:797.
    >> Share

  391. MOURAD A, Nwafo N, Skalla L, Holland TL, et al
    Oral versus intravenous antibiotic therapy for Staphylococcus aureus bacteremia or endocarditis: a systematic review and meta-analysis of randomized controlled trials.
    Clin Infect Dis. 2024 Sep 18:ciae476. doi: 10.1093.
    >> Share

  392. PROSTY C, Lee TC, McDonald EG
    Is More Always Better? Rethinking Monotherapy for Enterococcus faecalis Infective Endocarditis.
    Clin Infect Dis. 2024 Sep 6:ciae458. doi: 10.1093.
    >> Share

  393. DANNEELS P, Hamel JF, Dubee V
    Adjunctive Therapy in Enterococcus faecalis Endocarditis Treatment: Maybe Less is Not Enough.
    Clin Infect Dis. 2024 Sep 6:ciae459. doi: 10.1093.
    >> Share

  394. SEIFERT M, Catanzaro DG, Gracia M, Hillery N, et al
    Prospective exploratory evaluation of Cepheid Xpert Mycobacterium tuberculosis host response cartridge: a focus on adolescents and young adults.
    Clin Infect Dis. 2024 Sep 5:ciae461. doi: 10.1093.
    >> Share

    August 2024
  395. HO EC, Olson KE, Butler M, Birkholz M, et al
    Clinical impact of pleural fluid Streptococcus pneumoniae PCR testing in children with complicated pneumonia.
    Clin Infect Dis. 2024 Aug 29:ciae439. doi: 10.1093.
    >> Share

  396. PADMAPRIYADARSINI C, Oswal VS, Jain CD, Mariappan MV, et al
    Effectiveness and Safety of Varying Doses of Linezolid With Bedaquiline and Pretomanid in Treatment of Drug-Resistant Pulmonary Tuberculosis: Open-Label, Randomized Clinical Trial.
    Clin Infect Dis. 2024 Aug 28:ciae388. doi: 10.1093.
    >> Share

  397. BOSMAN S, Ayakaka I, Muhairwe J, Kamele M, et al
    Evaluation of C-Reactive Protein and Computer-Aided Analysis of Chest X-rays as Tuberculosis Triage Tests at Health Facilities in Lesotho and South Africa.
    Clin Infect Dis. 2024 Aug 27:ciae378. doi: 10.1093.
    >> Share

  398. DINH A, McNally M, D'Anglejan E, Mamona Kilu C, et al
    Prosthetic Joint Infections due to Candida Species: A Multicenter International Study.
    Clin Infect Dis. 2024 Aug 27:ciae395. doi: 10.1093.
    >> Share

  399. GAKURU J, Kagimu E, Dai B, Okurut S, et al
    Implementation of single high-dose liposomal amphotericin B based induction therapy for treatment of HIV-associated cryptococcal meningitis in Uganda: a comparative prospective cohort study.
    Clin Infect Dis. 2024 Aug 24:ciae413. doi: 10.1093.
    >> Share

  400. DONSKEY CJ, Dubberke ER, Klein NP, Liles EG, et al
    CLOVER: A Phase 3 Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of Clostridioides difficile Infection.
    Clin Infect Dis. 2024 Aug 24:ciae410. doi: 10.1093.
    >> Share

  401. PERI AM, Chatfield MD, Ling W, Furuya-Kanamori L, et al
    Rapid Diagnostic Tests and Antimicrobial Stewardship Programs for the Management of Bloodstream Infection: What Is Their Relative Contribution to Improving Clinical Outcomes? A Systematic Review and Network Meta-analysis.
    Clin Infect Dis. 2024;79:502-515.
    >> Share

  402. NARAYANAN N, Mathers AJ, Wenzler E, Moore NM, et al
    Amoxicillin-Clavulanate Breakpoints Against Enterobacterales: Rationale for Revision by the Clinical and Laboratory Standards Institute.
    Clin Infect Dis. 2024;79:516-523.
    >> Share

  403. WINSTON DJ, Young PA, Schlamm HT, Schiller GJ, et al
    Good Outcomes in Therapy of Fusariosis Depend on Both an Effective Drug and the Host.
    Clin Infect Dis. 2024;79:572.
    >> Share

  404. DUDOIGNON E, Camelena F, de Tymowski C, Lafaurie M, et al
    Shorter Versus Longer Course of Antibiotic Therapy for Gram-Negative Bacteremia: Time for a Tailored Duration?
    Clin Infect Dis. 2024;79:577-579.
    >> Share

  405. JAYASINGHE S, Williams PCM, Macartney KK, Crawford NW, et al
    Assessing the Impact of Pneumococcal Conjugate Vaccine Immunization Schedule Change From 3+0 to 2+1 in Australian Children: A Retrospective Observational Study.
    Clin Infect Dis. 2024 Aug 14:ciae377. doi: 10.1093.
    >> Share

  406. WONG A, Lima N, Applegate TL, Guy R, et al
    Viability of Chlamydia trachomatis in different anatomical sites - a systematic review & meta-analysis.
    Clin Infect Dis. 2024 Aug 5:ciae401. doi: 10.1093.
    >> Share

    July 2024
  407. SCOTT P, Haranaka M, Choi JH, Stacey H, et al
    A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-Experienced Adults 50 Years of Age or Older (Stride-6).
    Clin Infect Dis. 2024 Jul 31:ciae383. doi: 10.1093.
    >> Share

  408. SERRIS A, Rautemaa-Richardson R, Laranjinha J, Candoni A, et al
    European Study of Cerebral Aspergillosis treated with Isavuconazole: an EFISG study.
    Clin Infect Dis. 2024 Jul 30:ciae371. doi: 10.1093.
    >> Share

  409. MEYA DB, Nalintya E, Skipper CP, Kirumira P, et al
    Adjunctive Single-Dose Liposomal Amphotericin to Prevent Cryptococcal Meningitis in People With Human Immunodeficiency Virus (HIV)-Associated Cryptococcal Antigenemia and Low Plasma Cryptococcal Antigen (CrAg) Titers.
    Clin Infect Dis. 2024 Jul 24:ciae266. doi: 10.1093.
    >> Share

  410. HIRUY H, Bala S, Byrne JM, Roche KG, et al
    FDA, CDC, and NIH Co-sponsored Public Workshop Summary-Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea.
    Clin Infect Dis. 2024 Jul 24:ciae386. doi: 10.1093.
    >> Share

  411. PROSTY C, Sorin M, Katergi K, Khalaf R, et al
    Revisiting the Evidence Base Informing the Use of Adjunctive Therapy for Enterococcus faecalis Endocarditis: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2024 Jul 23:ciae379. doi: 10.1093.
    >> Share

  412. KAUPPINEN KJ, Aho I, Sjoblom N, Tynninen O, et al
    Effect of Two Forms of Tenofovir on Duodenal Enterocytes - a Hypothesis for Different Effect of TDF and TAF on Body Weight and Plasma Lipids.
    Clin Infect Dis. 2024 Jul 23:ciae374. doi: 10.1093.
    >> Share

  413. JARRETT BA, Shearer K, Motlhaoleng K, Chon S, et al
    Comparison of QuantiFERON Gold In-Tube Versus Tuberculin Skin Tests on the Initiation of Tuberculosis Preventive Therapy Among Patients Newly Diagnosed With Human Immunodeficiency Virus in the North West Province of South Africa (the Teko Study): A Cl
    Clin Infect Dis. 2024 Jul 22:ciae268. doi: 10.1093.
    >> Share

  414. BOUTIN CA, Durocher F, Beauchemin S, Ziegler D, et al
    Breakthrough Invasive Fungal Infections in Patients With High-Risk Hematological Disorders Receiving Voriconazole and Posaconazole Prophylaxis: A Systematic Review.
    Clin Infect Dis. 2024;79:151-160.
    >> Share

  415. KINAMON T, Waack U, Needles M, Rubin D, et al
    Exploration of a Potential DOOR Endpoint for Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia Using Six Registrational Trials for Antibacterial Drugs.
    Clin Infect Dis. 2024;79:60-69.
    >> Share

  416. MAILLARD A, Dortet L, Delory T, Lafaurie M, et al
    Mutation Rate of AmpC beta-Lactamase-Producing Enterobacterales and Treatment in Clinical Practice: A Word of Caution.
    Clin Infect Dis. 2024;79:52-55.
    >> Share

  417. TEMKIN E, Solter E, Lugassy C, Chen D, et al
    The Natural History of Carbapenemase-Producing Enterobacterales: Progression From Carriage of Various Carbapenemases to Bloodstream Infection.
    Clin Infect Dis. 2024;79:22-29.
    >> Share

  418. GIANNELLA M, Pascale R, Viale P
    Progression From Carriage to Bloodstream Infection and Fatality by Different Enterobacterales Species, Carbapenemases, and Host Settings: Deciphering the Melting Pot.
    Clin Infect Dis. 2024;79:30-32.
    >> Share

  419. EUBANK TA, Dureja C, Garey KW, Hurdle JG, et al
    Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Lower Rates of Initial Cure and Sustained Clinical Response.
    Clin Infect Dis. 2024;79:15-21.
    >> Share

  420. GROSSMAN MK, Rankin DA, Maloney M, Stanton RA, et al
    Extensively Drug-Resistant Pseudomonas aeruginosa Outbreak Associated With Artificial Tears.
    Clin Infect Dis. 2024;79:6-14.
    >> Share

  421. FRATONI AJ, Gethers ML, Nicolau DP, Kuti JL, et al
    Non-KPC Attributes of Newer beta-lactam/beta-lactamase Inhibitors, Part 1: Enterobacterales and Pseudomonas aeruginosa.
    Clin Infect Dis. 2024;79:33-42.
    >> Share

  422. NUSSBAUM EZ, Koo S, Kotton CN
    Oral Antibiotics for Treatment of Gram-Negative Bacteremia in Solid Organ Transplant Recipients: A Propensity Score Weighted Retrospective Observational Study.
    Clin Infect Dis. 2024;79:208-214.
    >> Share

  423. EDOSA M, Jeon Y, Gedefaw A, Hailu D, et al
    Comprehensive Review on the Use of Oral Cholera Vaccine (OCV) in Ethiopia: 2019 to 2023.
    Clin Infect Dis. 2024;79.
    >> Share

  424. WORKU DEMLIE Y, Gedefaw A, Jeon Y, Hailu D, et al
    Retrospective Analysis of Cholera/Acute Watery Diarrhea Outbreaks in Ethiopia From 2001 To 2023: Incidence, Case Fatality Rate, and Seasonal and Multiyear Epidemic Patterns.
    Clin Infect Dis. 2024;79.
    >> Share

  425. HUSSEN M, Worku Demlie Y, Edosa M, Kebede M, et al
    Ethiopia National Cholera Elimination Plan 2022-2028: Experiences, Challenges, and the Way Forward.
    Clin Infect Dis. 2024;79.
    >> Share

  426. HAILU D, Jeon Y, Gedefaw A, Kim JH, et al
    Dissecting Water, Sanitation, and Hygiene (WaSH) to Assess Risk Factors for Cholera in Shashemene, Oromia Region, Ethiopia.
    Clin Infect Dis. 2024;79.
    >> Share

  427. GETAHUN T, Hailu D, Mogeni OD, Mesfin Getachew E, et al
    Healthcare Seeking Behavior and Disease Perception Toward Cholera and Acute Diarrhea Among Populations Living in Cholera High-Priority Hotspots in Shashemene, Ethiopia.
    Clin Infect Dis. 2024;79.
    >> Share

  428. PARK SE, Gedefaw A, Hailu D, Jeon Y, et al
    Coverage of Two-Dose Preemptive Cholera Mass Vaccination Campaign in High-Priority Hotspots in Shashemene, Oromia Region, Ethiopia.
    Clin Infect Dis. 2024;79.
    >> Share

  429. PAPADIMITRIOU-OLIVGERIS M, Monney P, Frank M, Tzimas G, et al
    Comparison of the 2015 and 2023 European Society of Cardiology versions of the Duke criteria among patients with suspected infective endocarditis.
    Clin Infect Dis. 2024 Jul 12:ciae370. doi: 10.1093.
    >> Share

  430. PRAKASH BABU S, Ezhumalai K, Raghupathy K, Karoly M, et al
    Factors associated with unfavourable treatment outcomes among persons with Pulmonary Tuberculosis: a multicentric prospective cohort study from India.
    Clin Infect Dis. 2024 Jul 11:ciae367. doi: 10.1093.
    >> Share

  431. SORIANO A, Honore PM, Cornely OA, Chayakulkeeree M, et al
    Treatment Outcomes Among Patients With a Positive Candida Culture Close to Randomization Receiving Rezafungin or Caspofungin in the ReSTORE Study.
    Clin Infect Dis. 2024 Jul 10:ciae363. doi: 10.1093.
    >> Share

  432. WANG MS, Li-Hunnam J, Chen YL, Gilmour B, et al
    Conversion or reversion of interferon gamma release assays for Mycobacterium tuberculosis infection: a systematic review and meta-analysis.
    Clin Infect Dis. 2024 Jul 2:ciae357. doi: 10.1093.
    >> Share

  433. MOHAREB AM, Barshak MB, Papaliodis GN, Sobrin L, et al
    Ocular syphilis in patients with nonreactive RPR and positive treponemal serologies: a retrospective observational cohort study.
    Clin Infect Dis. 2024 Jul 2:ciae354. doi: 10.1093.
    >> Share

    June 2024
  434. KIMUDA S, Kwizera R, Dai B, Kigozi E, et al
    Comparison of early fungicidal activity and mortality between daily liposomal amphotericin B and daily amphotericin B deoxycholate among patients with HIV-associated cryptococcal meningitis.
    Clin Infect Dis. 2024 Jun 29:ciae326. doi: 10.1093.
    >> Share

  435. SWETS MC, Bakk Z, Westgeest AC, Berry K, et al
    Clinical sub-phenotypes of Staphylococcus aureus bacteraemia.
    Clin Infect Dis. 2024 Jun 25:ciae338. doi: 10.1093.
    >> Share

  436. ZHU Y, Forsman LD, Chen C, Zhang H, et al
    Drug exposure and treatment outcomes in patients with multidrug resistant tuberculosis and diabetes mellitus: A multicenter prospective cohort study from China.
    Clin Infect Dis. 2024 Jun 24:ciae329. doi: 10.1093.
    >> Share

  437. ALONSO-MENCHEN D, Marin-Arriaza M, Villamarin M, Fernandez-Hidalgo N, et al
    Cutibacterium species valvular and cardiac device-related infective endocarditis: contemporary data from the GAMES prospective cohort (2008-2023).
    Clin Infect Dis. 2024 Jun 24:ciae334. doi: 10.1093.
    >> Share

  438. RICHTERMAN A, Saintilien E, St-Cyr M, Claudia Gracia L, et al
    Food Insecurity at Tuberculosis Treatment Initiation Is Associated With Clinical Outcomes in Rural Haiti: A Prospective Cohort Study.
    Clin Infect Dis. 2024 Jun 18:ciae252. doi: 10.1093.
    >> Share

  439. KWAK N, Henkle E, Hwang H, Jeon D, et al
    Improvement in Health-Related Quality of Life Following Antibiotic Treatment in Nontuberculous Mycobacterial Pulmonary Disease: Initial Analysis of the NTM-KOREA Cohort.
    Clin Infect Dis. 2024;78:1690-1697.
    >> Share

  440. OLADAPO-SHITTU O, Cosgrove SE, Rock C, Hsu YJ, et al
    Characterizing Patients Presenting on Hospital Admission With Central Line-Associated Bloodstream Infections: A Multicenter Study.
    Clin Infect Dis. 2024;78:1632-1639.
    >> Share

  441. ANKRAH PK, Bock A, Ruffin F, Hanson BM, et al
    Persistent Gram-negative Bloodstream Infection Increases the Risk of Recurrent Bloodstream Infection With the Same Species.
    Clin Infect Dis. 2024;78:1458-1461.
    >> Share

  442. HARDY M, Harris PNA, Paterson DL, Chatfield MD, et al
    Win Ratio Analyses of Piperacillin-Tazobactam Versus Meropenem for Ceftriaxone-Nonsusceptible Escherichia coli or Klebsiella pneumoniae Bloodstream Infections: Post Hoc Insights From the MERINO Trial.
    Clin Infect Dis. 2024;78:1482-1489.
    >> Share

  443. OKHUYSEN PC, Ramesh MS, Louie T, Kiknadze N, et al
    A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response.
    Clin Infect Dis. 2024;78:1462-1472.
    >> Share

  444. SENCHYNA F, Murugesan K, Rotunno W, Nadimpalli SS, et al
    Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-beta-lactamase-Producing Escherichia coli Causing Fatal Bloodstream Infection.
    Clin Infect Dis. 2024;78:1425-1428.
    >> Share

  445. MORQUIN D, Lejeune J, Agostini C, Godreuil S, et al
    Time Is of the Essence: Achieving Prompt and Effective Antimicrobial Therapy of Bloodstream Infection With Advanced Hospital Information Systems.
    Clin Infect Dis. 2024;78:1434-1442.
    >> Share

  446. JJINGO CJ, Bala S, Waack U, Needles M, et al
    Food and Drug Administration Public Workshop Summary-Addressing Challenges in Inhaled Antifungal Drug Development.
    Clin Infect Dis. 2024;78:1564-1570.
    >> Share

  447. SMITH DJ, Free RJ, Thompson GR 3rd, Baddley JW, et al
    Clinical Testing Guidance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis in Patients With Community-Acquired Pneumonia for Primary and Urgent Care Providers.
    Clin Infect Dis. 2024;78:1559-1563.
    >> Share

  448. BROWN L, Rautemaa-Richardson R, Mengoli C, Alanio A, et al
    Polymerase Chain Reaction on Respiratory Tract Specimens of Immunocompromised Patients to Diagnose Pneumocystis Pneumonia: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2024 Jun 11:ciae239. doi: 10.1093.
    >> Share

  449. COOPER LN, Beauchamp AM, Ingle TA, Diaz MI, et al
    Socioeconomic Disparities and the Prevalence of Antimicrobial Resistance.
    Clin Infect Dis. 2024 Jun 7:ciae313. doi: 10.1093.
    >> Share

  450. FOURRE N, Zimmermann V, Senn L, Monney P, et al
    Evaluation of the HANDOC score and the 2023 ISCVID and ESC Duke clinical criteria for the diagnosis of infective endocarditis among patients with streptococcal bacteremia.
    Clin Infect Dis. 2024 Jun 6:ciae315. doi: 10.1093.
    >> Share

  451. DEQUIDT T, Boutellis J, Coussement J
    Relationship between appropriateness of empirical antibiotic therapy and mortality in patients with streptococcal bloodstream infection.
    Clin Infect Dis. 2024 Jun 6:ciae312. doi: 10.1093.
    >> Share

  452. FOURRE N, Guery B, Papadimitriou-Olivgeris M
    Factors contributing to delayed initiation of appropriate antimicrobial treatment in patients with streptococcal bacteremia.
    Clin Infect Dis. 2024 Jun 6:ciae317. doi: 10.1093.
    >> Share

  453. TESHOME BF, Park T, Arackal J, Hampton N, et al
    Preventing New Gram-negative Resistance Through Beta-lactam De-escalation in Hospitalized Patients With Sepsis: A Retrospective Cohort Study.
    Clin Infect Dis. 2024 Jun 6:ciae253. doi: 10.1093.
    >> Share

  454. RASHITOV M, Franke M, Trevisi L, Bekbolatova G, et al
    Safety and effectiveness of three novel all-oral shortened regimens for rifampicin- or multidrug-resistant tuberculosis in Kazakhstan.
    Clin Infect Dis. 2024 Jun 4:ciae305. doi: 10.1093.
    >> Share

  455. ABBOTT R, Landsiedel K, Atukunda M, Puryear SB, et al
    Incident Tuberculosis Infection is Associated with Alcohol use in Adults in Rural Uganda.
    Clin Infect Dis. 2024 Jun 2:ciae304. doi: 10.1093.
    >> Share

    May 2024
  456. ANPALAGAN K, Dotel R, MacFadden DR, Smith S, et al
    Does adjunctive clindamycin have a role in Staphylococcus aureus bacteremia? A protocol for the adjunctive treatment domain of the S. aureus Network Adaptive Platform (SNAP) randomized controlled trial.
    Clin Infect Dis. 2024 May 27:ciae289. doi: 10.1093.
    >> Share

  457. RUSSELL CD, Berry K, Cooper G, Sim W, et al
    Distinct clinical endpoints of Staphylococcus aureus bacteraemia complicate assessment of outcome.
    Clin Infect Dis. 2024 May 20:ciae281. doi: 10.1093.
    >> Share

  458. PINEDA-REYES R, Neil BH, Orndorff J, Williams-Bouyer N, et al
    Clinical presentation, antimicrobial resistance, and treatment outcomes of Aeromonas human infections: A 14-year retrospective study and comparative genomics of two isolates from fatal cases.
    Clin Infect Dis. 2024 May 17:ciae272. doi: 10.1093.
    >> Share

  459. GETANDA P, Jagne I, Bognini JD, Camara B, et al
    Impact of Intrapartum Azithromycin on the Carriage and Antibiotic Resistance of Escherichia coli and Klebsiella pneumoniae in Mothers and their Newborns: a sub-study of a Randomized Double-Blind Trial Conducted in The Gambia and Burkina Faso.
    Clin Infect Dis. 2024 May 16:ciae280. doi: 10.1093.
    >> Share

  460. BURKE RM, Nyirenda SK, Mtenga T, Twabi HH, et al
    Enhanced tuberculosis diagnosis with computer-aided chest X-ray and urine LAM in adults with HIV admitted to hospital (CASTLE study): A cluster randomised trial.
    Clin Infect Dis. 2024 May 15:ciae273. doi: 10.1093.
    >> Share

  461. HAMILL MM, Ghanem KG, Tuddenham S
    Executive Summary: State-of-the-Art Review: Neurosyphilis.
    Clin Infect Dis. 2024;78:1085-1087.
    >> Share

  462. PLYMOTH M, Lundqvist R, Nystedt A, Sjostedt A, et al
    Targeting Tularemia: Clinical, Laboratory, and Treatment Outcomes From an 11-year Retrospective Observational Cohort in Northern Sweden.
    Clin Infect Dis. 2024;78:1222-1231.
    >> Share

  463. FALCONE M, Giordano C, Leonildi A, Galfo V, et al
    Clinical Features and Outcomes of Infections Caused by Metallo-beta-Lactamase-Producing Enterobacterales: A 3-Year Prospective Study From an Endemic Area.
    Clin Infect Dis. 2024;78:1111-1119.
    >> Share

  464. HAREZA DA, Cosgrove SE, Simner PJ, Harris AD, et al
    Is Carbapenem Therapy Necessary for the Treatment of Non-CTX-M Extended-Spectrum beta-Lactamase-Producing Enterobacterales Bloodstream Infections?
    Clin Infect Dis. 2024;78:1103-1110.
    >> Share

  465. CORTES-PENFIELD NW, Musher DM
    Give Penicillin or Ceftriaxone: Neurosyphilis Does Not Deal in Absolutes.
    Clin Infect Dis. 2024;78:1386-1387.
    >> Share

  466. XIE L, Li W, Ye WM, Xiao Y, et al
    Enhancing Neurosyphilis Diagnosis: Evaluating Novel Biomarkers and Clinical Implementation Challenges.
    Clin Infect Dis. 2024;78:1385-1386.
    >> Share

  467. ITO H
    Enhancing Neurosyphilis Diagnosis: Evaluating Serum Biomarkers as Non-Invasive Alternatives to Lumbar Puncture.
    Clin Infect Dis. 2024;78:1384-1385.
    >> Share

  468. HAMILL MM, Ghanem KG, Tuddenham S
    State-of-the-Art Review: Neurosyphilis.
    Clin Infect Dis. 2024;78:e57-e68.
    >> Share

  469. SHAH NS, Kityo C, Hughes MD, McCarthy C, et al
    Effectiveness of double-dose dolutegravir in people receiving rifampin-based tuberculosis treatment: an observational, cohort study of people with HIV from six countries.
    Clin Infect Dis. 2024 May 13:ciae269. doi: 10.1093.
    >> Share

  470. DANIELS E, Atkinson A, Cardoza N, Ramakrishnan A, et al
    Social Factors Associated with Congenital Syphilis in Missouri.
    Clin Infect Dis. 2024 May 12:ciae260. doi: 10.1093.
    >> Share

  471. LAMAS C
    Correspondence on the validation of the Duke-ISCVID criteria for the diagnosis of infective endocarditis: what of the new major microbiological criteria?
    Clin Infect Dis. 2024 May 3:ciae217. doi: 10.1093.
    >> Share

    April 2024
  472. SRIVATHSAN A, Abdou A, Al-Khatib T, Apadinuwe SC, et al
    District-Level Forecast of Achieving Trachoma Elimination as a Public Health Problem By 2030: An Ensemble Modelling Approach.
    Clin Infect Dis. 2024;78.
    >> Share

  473. SUNNERHAGEN T, Rasmussen M
    Lower specificity of the ESC2023 diagnostic criteria for infective endocarditis when spondylodiscitis is regarded as a vascular phenomenon.
    Clin Infect Dis. 2024 Apr 24:ciae223. doi: 10.1093.
    >> Share

  474. RANZENIGO M, van Soest TM, Hensen EF, Cinque P, et al
    Otitis in patients with Community-Acquired Bacterial Meningitis: A Nationwide Prospective Cohort Study.
    Clin Infect Dis. 2024 Apr 24:ciae221. doi: 10.1093.
    >> Share

  475. OLDBERG K, Rasmussen M
    Make modern microbiology matter more in the 2023 ESC guidelines for the management of infective endocarditis.
    Clin Infect Dis. 2024 Apr 24:ciae222. doi: 10.1093.
    >> Share

  476. SINHA P, Ezhumalai K, Du X, Ponnuraja C, et al
    Undernourished Household Contacts Are at Increased Risk of Tuberculosis (TB) Disease, but not TB Infection- a Multicenter Prospective Cohort Analysis.
    Clin Infect Dis. 2024 Apr 23:ciae149. doi: 10.1093.
    >> Share

  477. FIGGATT MC, Rosen DL, Chu VH, Wu LT, et al
    Long-term risk of serious infections and mortality among patients surviving drug use-associated infective endocarditis.
    Clin Infect Dis. 2024 Apr 20:ciae214. doi: 10.1093.
    >> Share

  478. SHRESTHA NK, Kanyo EC, Nakhoul GN, Herlitz LC, et al
    Association between Causative Pathogen and Occurrence of Infection-Related Glomerulonephritis in Infective Endocarditis.
    Clin Infect Dis. 2024 Apr 18:ciae213. doi: 10.1093.
    >> Share

  479. FARHAT MR, Jacobson KR
    For Tuberculosis, Not "To Screen or Not to Screen?" but "Who?" and "How?".
    Clin Infect Dis. 2024 Apr 18:ciae058. doi: 10.1093.
    >> Share

  480. GOSWAMI N, Reed C
    Duration of Effective Tuberculosis Treatment, not Acid-Fast Bacilli (AFB) Smear Status, as the Determinant for Deisolation in Community Settings.
    Clin Infect Dis. 2024 Apr 18:ciae198. doi: 10.1093.
    >> Share

  481. SHAH M, Dansky Z, Nathavitharana R, Behm H, et al
    NTCA Guidelines for Respiratory Isolation and Restrictions to Reduce Transmission of Pulmonary Tuberculosis in Community Settings.
    Clin Infect Dis. 2024 Apr 18:ciae199. doi: 10.1093.
    >> Share

  482. TAMMA PD, Immel S, Karaba SM, Soto CL, et al
    Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis with Sulbactam-Durlobactam.
    Clin Infect Dis. 2024 Apr 17:ciae210. doi: 10.1093.
    >> Share

  483. RUBIS AB, Cole M, Tondella ML, Pawloski LC, et al
    Assessing the Impact of the 2020 Council of State and Territorial Epidemiologists Case Definition for Pertussis on Reported Pertussis Cases.
    Clin Infect Dis. 2024 Apr 12:ciae207. doi: 10.1093.
    >> Share

  484. CHASTAIN DB, Spradlin M, Ahmad H, Henao-Martinez AF, et al
    Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.
    Clin Infect Dis. 2024;78:811-812.
    >> Share

  485. MARINER-LLICER C, Saavedra Cervera B, Mambuque E, Gomes N, et al
    Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique.
    Clin Infect Dis. 2024;78:842-845.
    >> Share

  486. MIKIASHVILI L, Kempker RR, Chakhaia TS, Bablishvili N, et al
    Impact of Prior Tuberculosis Treatment With New/Companion Drugs on Clinical Outcomes in Patients Receiving Concomitant Bedaquiline and Delamanid for Multidrug- and Rifampicin-Resistant Tuberculosis.
    Clin Infect Dis. 2024;78:1043-1052.
    >> Share

  487. UJIIE M
    Tetanus Toxoid Antibody Seroprevalence in Japan.
    Clin Infect Dis. 2024;78:1079-1080.
    >> Share

  488. QIU J, Zimmet AN, Bell TD, Gadrey S, et al
    Pathophysiological Responses to Bloodstream Infection in Critically Ill Transplant Recipients Compared With Non-Transplant Recipients.
    Clin Infect Dis. 2024;78:1011-1021.
    >> Share

  489. CHABALA C, Wobudeya E, van der Zalm MM, Kapasa M, et al
    Clinical outcomes in children living with HIV treated for non-severe tuberculosis in the SHINE Trial.
    Clin Infect Dis. 2024 Apr 9:ciae193. doi: 10.1093.
    >> Share

  490. HENDRIKS MMC, Schweren KSA, Kleij A, Berrevoets MAH, et al
    Low-risk Staphylococcus aureus bacteremia patients do not require routine diagnostic imaging: A multicenter retrospective cohort study.
    Clin Infect Dis. 2024 Apr 5:ciae187. doi: 10.1093.
    >> Share

  491. SHIELDS RK, Cheng WY, Kponee-Shovein K, Indacochea D, et al
    Development of Predictive Models to Inform a Novel Risk Categorization Framework for Antibiotic Resistance in E. coli-Causing Uncomplicated Urinary Tract Infection.
    Clin Infect Dis. 2024 Apr 4:ciae171. doi: 10.1093.
    >> Share

  492. RODRIGUEZ-MOLINO P, Tebruegge M, Noguera-Julian A, Neth O, et al
    Tuberculosis disease in immunocompromised children and adolescents: a pTBnet multi-centre case-control study.
    Clin Infect Dis. 2024 Apr 3:ciae158. doi: 10.1093.
    >> Share

    March 2024
  493. BERTUMEN JB, Pascopella L, Han E, Glenn-Finer R, et al
    Epidemiology and Treatment Outcomes of Tuberculosis with Chronic Hepatitis B Infection-California, 2016-2020.
    Clin Infect Dis. 2024 Mar 26:ciae169. doi: 10.1093.
    >> Share

  494. FOURRE N, Zimmermann V, Senn L, Aruanno M, et al
    Predictors of mortality of streptococcal bacteremia and the role of infectious diseases consultation; a retrospective cohort study.
    Clin Infect Dis. 2024 Mar 25:ciae168. doi: 10.1093.
    >> Share

  495. MORGAN H, Ndjeka N, Hasan T, Gegia M, et al
    Treatment of multidrug-resistant or rifampicin-resistant tuberculosis with an all-oral 9-month regimen containing linezolid or ethionamide in South Africa: A retrospective cohort study.
    Clin Infect Dis. 2024 Mar 25:ciae145. doi: 10.1093.
    >> Share

  496. SAKOULAS G, Tsou EE, Geriak M, Vasina L, et al
    Contemporary Management of Staphylococcus aureus Bacteremia: Some Additional Considerations for Clinicians.
    Clin Infect Dis. 2024 Mar 20:ciae080. doi: 10.1093.
    >> Share

  497. SUNSTRUM J, Power LE, Fligiel HM, Lauter C, et al
    Human Disease due to Mycobacterium bovis Linked to Free-Ranging Deer in Michigan.
    Clin Infect Dis. 2024;78:637-645.
    >> Share

  498. BOODMAN C, Gupta N, Nelson CA, van Griensven J, et al
    Bartonella quintana Endocarditis: A Systematic Review of Individual Cases.
    Clin Infect Dis. 2024;78:554-561.
    >> Share

  499. KRISHNAN S, Chaisson RE
    US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.
    Clin Infect Dis. 2024;78:514-517.
    >> Share

  500. FRANCOIS WATKINS LK, Luna S, Bruce BB, Medalla F, et al
    Clinical Outcomes of Patients With Nontyphoidal Salmonella Infections by Isolate Resistance-Foodborne Diseases Active Surveillance Network, 10 US Sites, 2004-2018.
    Clin Infect Dis. 2024;78:535-543.
    >> Share

  501. FENG X, Qian C, Fan Y, Li J, et al
    Is Short-Course Antibiotic Therapy Suitable for Pseudomonas aeruginosa Bloodstream Infections in Onco-hematology Patients With Febrile Neutropenia? Results of a Multi-institutional Analysis.
    Clin Infect Dis. 2024;78:518-525.
    >> Share

  502. MUTHU V, Agarwal R
    Pulmonary Artery Aneurysms: Mycotic or Mycobacterial?
    Clin Infect Dis. 2024;78:805-806.
    >> Share

  503. MOHANTY S, Ye G, Sheets C, Cossrow N, et al
    Association Between Social Vulnerability and Streptococcus pneumoniae Antimicrobial Resistance in US Adults.
    Clin Infect Dis. 2024 Mar 14:ciae138. doi: 10.1093.
    >> Share

  504. MINTER DJ, Appa A, Chambers HF, Doernberg SB, et al
    The positioning of ceftobiprole in the treatment of Staphylococcus aureus bacteremia.
    Clin Infect Dis. 2024 Mar 11:ciae126. doi: 10.1093.
    >> Share

  505. MEMBRILLO DE NOVALES FJ, Bravo de Pablo O, Estella Garcia A, Morata Ruiz L, et al
    The positioning of ceftobiprole in Staphylococcus aureus bacteremia.
    Clin Infect Dis. 2024 Mar 11:ciae123. doi: 10.1093.
    >> Share

  506. NGO HX, Xu AY, Velasquez GE, Zhang N, et al
    Pharmacokinetic-Pharmacodynamic Evidence from a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
    Clin Infect Dis. 2024 Mar 11:ciae119. doi: 10.1093.
    >> Share

  507. TANNOUS E, Lipman-Arens S, Cohen R
    Should a minimum Daptomycin AUC24h of 666 mg/L/h be the target in Staphylococcus aureus infections?
    Clin Infect Dis. 2024 Mar 6:ciae086. doi: 10.1093.
    >> Share

    February 2024
  508. CROCKER-BUQUE T, Lachenal N, Narasimooloo C, Abdrasuliev T, et al
    Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL.
    Clin Infect Dis. 2024 Feb 29:ciad767. doi: 10.1093.
    >> Share

  509. BRADLEY JS, Bulitta JB, Cook R, Yu PA, et al
    Central Nervous System Antimicrobial Exposure and Proposed Dosing for Anthrax Meningitis.
    Clin Infect Dis. 2024 Feb 27:ciae093. doi: 10.1093.
    >> Share

  510. TEIXEIRA LAA, Santos B, Correia MG, Valiquette C, et al
    Long-term protective effect of tuberculosis preventive therapy in a medium/high TB incidence setting.
    Clin Infect Dis. 2024 Feb 26:ciae101. doi: 10.1093.
    >> Share

  511. STEADMAN A, Andama A, Ball A, Mukwatamundu J, et al
    New manual qPCR assay validated on tongue swabs collected and processed in Uganda shows sensitivity that rivals sputum-based molecular TB diagnostics.
    Clin Infect Dis. 2024 Feb 2:ciae041. doi: 10.1093.
    >> Share

    January 2024
  512. BONOMO RA, Perez F, Hujer AM, Hujer KM, et al
    The Real Crisis in Antimicrobial Resistance: Failure to Anticipate and Respond.
    Clin Infect Dis. 2024 Jan 30:ciad758. doi: 10.1093.
    >> Share

  513. FENG X, Qian C, Fan Y, Li J, et al
    The Necessity of Studying Antibiotic Duration in Acute Leukemia Patients With Pseudomonas aeruginosa Bloodstream Infection: A Response to Terada and Kanno.
    Clin Infect Dis. 2024 Jan 17:ciae013. doi: 10.1093.
    >> Share

  514. MATSUO T, Wurster S, Kontoyiannis DP
    Good Outcomes in Salvage Therapy of Fusariosis in Patients With Leukemia: Is It the Host or the Drug?
    Clin Infect Dis. 2024 Jan 4:ciad768. doi: 10.1093.
    >> Share

    December 2023
  515. RYBAK A, Assad Z, Levy C, Bonarcorsi S, et al
    Age-specific resurgence in invasive pneumococcal disease incidence in the COVID-19 pandemic era and its association with respiratory virus and pneumococcal carriage dynamics: a time series analysis.
    Clin Infect Dis. 2023 Dec 6:ciad746. doi: 10.1093.
    >> Share

  516. DOUD MB, Haste NM, Abeles SR
    Correspondence to Hasegawa et al. "Diagnostic Accuracy of Hospital Antibiograms in Predicting the Risk of Antimicrobial Resistance in Enterobacteriaceae Isolates: A Nationwide Multicenter Evaluation at the Veterans Health Administration".
    Clin Infect Dis. 2023 Dec 6:ciad748. doi: 10.1093.
    >> Share

    November 2023
  517. BOULWARE DR
    When Someone Should Do Something About This: How a Cryptococcal Clinical Trialist Became Involved With the Coronavirus Disease 2019 Pandemic.
    Clin Infect Dis. 2023 Nov 16:ciad648. doi: 10.1093.
    >> Share

    October 2023
  518. STRAUB TJ, Lombardo MJ, Bryant JA, Diao L, et al
    Impact of a purified microbiome therapeutic on abundance of antimicrobial resistance genes in patients with recurrent Clostridioides difficile infection.
    Clin Infect Dis. 2023 Oct 12:ciad636. doi: 10.1093.
    >> Share

  519. YANG E, Sajhwani D, Fassnacht R, Mehta L, et al
    High rates of acquisition of toxigenic Clostridioides difficile colonization without subsequent infection during acute lymphoblastic leukemia treatment in children.
    Clin Infect Dis. 2023 Oct 11:ciad628. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016